Download Curriculum Vitae - American Headache Society

1
Stewart J. Tepper, MD
Curriculum Vitae
Phone: 914-469-1658
Land line: 508-432-7121
Email:
[email protected]
Professional information
Accepted position, Dartmouth Medical College/Dartmouth Hitchcock Medical
Center Department of Neurology Headache
Center Staff with Professorship
2015
Cleveland Clinic Headache Center Staff
Education:
2008-2015
Bachelor of Arts, Cum Laude, Honors in
Psychobiology, Yale College, 1975
MD, Cornell University Medical College, 1979
Career:
1979-1980, Intern, Internal Medicine, Boston
University Hospital, Boston City Hospital,
Boston, MA
1980-1981 Junior Residency, Internal Medicine,
University of Washington School of Medicine,
Seattle, WA
1981-1984 Neurology Residency, Longwood
Area Neurology Training Program, Harvard
Medical School, Boston, MA
University positions:
Current: Professor of Medicine (Neurology)
Cleveland Clinic Lerner College of Medicine
Case Western University
Cleveland, OH, 2009- 2015
2
Associate Clinical Professor of Neurology
Yale University School of Medicine Department
of Neurology, New Haven, CT 2006-2008
Assistant Clinical Professor of Neurology
Yale University School of Medicine Department
of Neurology, New Haven, CT 2001-2006
Clinical Assistant Professor of Neurology
University of Washington Department of
Neurology, Seattle, Washington 1988- 2000
Other positions:
Co-Director of Research
Center for Neurological Restoration
Neurological Institute
Cleveland Clinic, 2008- 2015
Director of Resident Research
Department of Neurology
Neurological Institute
Cleveland Clinic, 2009- 2015
Board Certification:
Neurology and Psychiatry, 1986,
American Board of Neurology and Psychiatry
Headache Medicine, United Council for
Neurologic Subspecialties, 2006
Professional Service:
Editor-in Chief, Headache Currents, second journal of the American
Headache Society (AHS), 2012- present
Associate Editor, Headache, journal of the American Headache Society
(AHS), 2008- present
President, North Central Headache Society (formerly the Ohio Headache
Association), 2014- 2015
Board of Directors, North Central Headache Society (Ohio Headache
Association), 2008- 2015
Scientific Advisory Board, Association of Migraine Disorders, 2014present
3
Course Co-Director, Scottsdale Headache Symposium of the American
Headache Society, 2008- present
Education Committee, American Headache Society, 2007- present
Vice President, New York State Neurologic Society, 2006-2007
Executive Board of Directors,
Headache Cooperative of New England, 2001- 2008
Headache Care for Practicing Clinicians, 2002present
American Council of Headache Education, 20042006
North Central Headache Society (formerly Ohio
Headache Association), 2009- present
President,
Puget Sound Neurological Society, 1989-1990
Course Director, Headache Therapy, American Academy of Neurology,
2009-2011
Course Co-Director, Winter Meeting of the American Headache
Society, 2002, 2005- 2007
Abstracts Editor, Headache, journal of the American Headache Society
(AHS), 2002- 2008
Education and Membership Committee, International Headache
Society 1998- 2003
Editor, North America, Headache Care, journal of Headache Care for
Practising Clinicians (HCPC), 2003- 2009
Clinical Science Contributing Editor, Headache Currents, 2006- 2009
Journal Editorial Board member:
Headache, 2002- present
Headache Care, 2004- 2007
Current Drug Safety, 2005- present
US Neurology, 2010-2011
Frontiers in Headache Medicine and Facial Pain, 2010- 2011
Neurology and Therapy, 2014- present
4
Director: The New England Center for Headache, Stamford, CT 19992007
Director: The New England Research Institute, Stamford, CT 1999-2007
Abstracts Reviewer, American Academy of Neurology, 2001-2004
Scientific Abstracts and Poster Reviewer, Headache Care for
Practicing Physicians and World Headache 2000, Scientific Abstract
reviewer, 2000
Quality Assurance Improvement Committee, Providence Medical Center,
Seattle, WA, 1987-1997
American Health Care Policy and Research (AHCPR) Group on Headache
1995-1997
Society memberships: Fellow, American Headache Society; International
Headache Society, North Central Headache Society (formerly
Ohio Headache Association), American Neurological
Association, North American Neuromodulation Society
Advisory Boards and Consultant, 2006-2015
Acorda, Allergan, Amgen, AstraZeneca, Autonomic Technologies, Inc,
Avanir/Otsuka, Axon Advisors, BristolMeyerSquibb, Coherex, DepoMed,
Dr. Reddy’s, Elan, Endo, Forrest, GersonLehmanGroup, GSK, Guidepoint
Global, Helsinn, Impax, Isis, Labrys, MAP, Medpointe, Merck, NMT,
Nautilus, NuPathe, OrthoMcNeil, Optinose, Pharmacia, Pfizer,
ScionNeurostim, Teva, UCB, USWorldMeds, Vernalis, Winston, Xcel,
Zogenix, Zosana
Cleveland Clinic Committees
Neurological Institute Residency Research Trainee Project Committee
2008- 2015
Neurosciences Specialty Panel (Pharmacy and Therapeutics), 2009- 2015
Neurological Institute Research Council, 2013- 2015
Neurological Institute Steering Committee for Cleveland Clinic Numoda
Joint Venture, 2010-2011
Neurological Institute Research Committee, 2008-2012
5
Professional Honors or Recognition:
Visiting Professor, Canadian Headache Society,
2015
International Headache Society Visiting
Professor, Mumbai, India, 2013
Elected Fellow of the American Headache
Society, 2012
Elected to American Neurological
Association, 2011
Best Doctors 2009-2014, Cleveland Magazine
Best Doctors (national), 2011-2013
Cleveland SuperDoctors, 2012
Best of the Best Award for abstract, American
Academy of Neurology, 2001
Outstanding Teaching Awards:
American Academy of Family Physicians,
Seattle Providence Medical Center 1988
Seattle Swedish Medical Center 1988-1993
American Headache Society Neurology
Ambassador Program Core Faculty, 2000-2004
Examiner, American Board of Neurology and
Psychiatry, 1996
Moderator
Scientific Sessions, American Academy of
Neurology, 2001, 2002, 2003
American Association for the Study of
Headache 1995, 1996, 1997, 1999
6
American Headache Society meetings 20052015
National Headache Foundation, 1st Annual
Research Symposium, 2004
American Headache Society, Scottsdale, 2004,
2013-2015
Cambridge Who’s Who, 2010;Best Doctors in
America, 2007-; Best Doctors in
Connecticut/America, 2002, 2003, 2005, 2006;
Strathmore’s National Who’s Who, 1999-;
Strathmore’s Worldwide Who’s Who 2009-;
Marquis Who’s Who in America, 1997-2008;
Marquis Who’s Who in Science and
Engineering 2006-9; Who’s Who in Medicine
and Healthcare 2006-7; Who’s Who in the
World 2006; Who’s Who in the 21st Century,
2001; Outstanding 2000 Intellectuals of the 21st
Century, 2001, both Cambridge, UK:
International Biographical Centre; Cambridge
Who’s Who Among Professionals in Research
Medicine and Healthcare, 2006; Top Doctors
for Women, Connecticut Magazine, 2002,
America’s Registry of Outstanding
Professionals, 2003-4, Metropolitan
Professional Registry, 2004
Consultant Reviewer:
King County Medical Regence Blue Shield
1993-1999
PRO-West, Professional Review Organization
for Medicare 1991-1999
Faculty:
Physician Teleconference Network 1996-2001.
E-scape migraine, Snyder Communications,
1999.
Primary Care Network, 1999-2009
Featured Guest, “Migraine” The Infinite Mind,
National Public Radio, 2/14/01, available at
www.lichtensteincreativemedia.com
Lecturer and Facilitator, Primary Care Network,
2001- 2009
NPACE Nurse Practitioner national CME,
2003-2009
Primed, 1999, 2008-2009
7
Medical Licensure:
Ohio 2008- present
Connecticut State 1999-2008
New York State 1999- 2008
Washington State 1984- 2008
Peer Journal Participation:
Reviewer for the following journals:
1. Cephalalgia
2. Clinical Drug Investigation
3. CNS Drugs
4. Drug Evaluation
5. European Journal of Neurology
6. Expert Opinion on Investigational Drugs
7. Expert Review of Neurotherapeutics
8. Future Drugs
9. Headache
10. Headache Care
11. Journal of Headache and Pain
12. The Lancet Neurology
13. Medical Science Monitor
14. Neurology
15. Neuroscience
16. Pharmacogenomics
17. Primary Care Consultant
18. Women’s Health in Primary Care
19. American Journal of Managed Care
20. Neurology India
21. Expert Opinion on Pharmacotherapy
22. Journal of Neurology, Neurosurgery and Psychiatry
23. American Journal of Cardiology
24. Journal of Women’s Health
25. Pain Practice
26. Clinical Medicine: Therapeutics
27. International Journal of Vascular Medicine
Medical Societies
American Neurological Association
American Headache Society/American Association for the Study of Headache
International Headache Society
National Headache Foundation
8
American Council for Headache Education
American Academy of Neurology
North Pacific Society of Neurology and Psychiatry
Puget Sound Neurological Society
Washington State Medical Association
King County Medical Society
Fairfield County Medical Society
Connecticut Medical Society
Ohio Headache Society/North Central Headache Society
Lectures, Courses:
Prevention of Headache Recurrence, Migraine Symposium, Scientific
Session, American Academy of Neurology, Boston, Mass, April, 1994.
Original Syllabus contribution.
Pathophysiology and Pharmacology of Migraine. XVI Annual US Army
Medical Department Neurology Conference (AMEDD). Madigan Army
Medical Center, Tacoma, WA, Nov 21, 1996. Original Syllabus
contribution.
When should we use 5HT agonists and when might they be used in
preference to other treatments such as ergotamines and combination
therapies, in New Horizons in Migraine symposium, XVIth World
Congress of Neurology, Buenos Aires, Argentina, September 13, 1997.
Pharmacologic Treatment of Primary Headache Disorders: Acute
Strategies, in Headache: Management and Therapy, Full-day Course on
Headache, XVIth World Congress of Neurology, Buenos Aires, Argentina,
September 14, 1997. Original Syllabus contribution.
Zolmitriptan in clinical practice - establishing the role of 5HT1B/1D
receptor agonists in migraine, symposium at the XVIth World Congress of
Neurology 15 September 1997, Buenos Aires, Argentina.
Ergots and Migraine, Treatment of Migraine, International Symposium, St
John’s College, Cambridge University, Cambridge, England, April 1998.
Epidemiology of Migraine and the Burden of Disease, The Causes of
Migraine- Pathophysiology and the Triptans, International Media
Symposium, Warren House, London, England, April 1998
Maximizing Treatment Response to Acute Migraine Therapy. American
Association for the Study of Headache, San Francisco, Cal. June 1998.
9
Patient Reported Tablet Utilization of Zolmitriptan and Sumatriptan.
Platform presentation, American Association for the Study of Headache,
San Francisco, Cal. June 1998.
Tolerability of Sumatriptan Nasal Spray in the Acute Treatment of
Migraine: A Review of Data from Clinical Trials. Platform presentation,
American Association for the Study of Headache, San Francisco, Cal. June
1998.
Clinical Use of Zolmitriptan, ADITUS Medical Media Workshop II- New
Migraine Treatments and Management Strategies, NY Academy of
Medicine, NY, NY June 1998.
Rational Migraine Management - Optimising Treatment with
Zolmitriptan: What do Physicians Want? 3rd European Federation of
Neurologic Societies, Seville, Spain, September 21st, 1998.
ADITUS Medical Media Workshop III- New Migraine Treatments and
Strategies, 3rd European Federation of Neurologic Societies, Seville,
Spain, Sept 22, 1998.
The new triptans (5-HT 1B/1D agonists) for acute treatment of migraine: a
clinical review using number needed to treat (NNT) analysis. Platform
presentation, 3rd European Federation of Neurological Societies, Seville,
Spain, Sept 21, 1998.
Benchmarks for Patient Satisfaction, Evaluating Triptans, Rome, April 3,
1999.
Managing Migraine, Paris, March 20, 1999; April 10, 1999.
Ergots or Triptans? XIII International Congress of the Brazilian Headache
Society, Salvador, Brazil, May 15, 1999
Migraine Research- Today and in the Future, and The Triptans- 1999
Comparative Review, at Changing the Face of Migraine, St John’s
College, Cambridge University, Cambridge, England, May 16-19, 1999.
Moderator: American Association for the Study of Headache 1995-1999:
Prepared questions and led platform discussion.
Scientific Basis of Migraine, in Scientific Basis of Neurology I course,
American Academy of Neurology, San Diego, CA, Apr 30, 2000. Original
Syllabus contribution.
10
Reducing the cost of impairment of Normal Activities due to Migraine: A
Stratified-Care Approach. Platform presentation, American Headache
Society, Montreal, Canada. June, 2000.
Pathophysiology of Migraine, Yale University School of Medicine
Department of Neurology Grand Rounds, June, 2000.
Migraine and Tension Type Headache, Vanderbilt University Medical
School, Nashville, TN, Department of Neurology Grand Rounds, 2000.
Understanding Patient Preference, in Rizatriptan: Meeting the Needs of
More Migraine Patients Symposium, Headache World 2000, London, UK.
Sept 5, 2000.
What do patients want in acute migraine treatment? Symposium,
European Federation of Neurological Societies, Copenhagen, Denmark,
October 2000.
Clinical Headache Update Symposium, “Rizatriptan Update”, Mexican
Academy of Neurology Congress, Acapulco, Mexico November 16, 2000.
Pathophysiology of Migraine. Grand Rounds, Indiana University School
of Medicine, Department of Neurology, Feb 8, 2001.
Triptan Clinical Efficacy, Clinical Endpoints, and Disability, in
Addressing the Burdens of Migraine: Clinical and Treatment Strategies,
Mallorca, Spain, March 10, 2001, also with two workshops in Barcelona,
Spain March 24, 2001.
Optimizing Acute Therapy- A Case for Early Intervention in Treatment of
Headache and Facial Pain course with the NY Headache Foundation,
NY, NY April 29, 2001.
Acute Treatment of Migraine, in Headache Therapy course, American
Academy of Neurology, Philadelphia, PA, May 10, 2001. Original
Syllabus contribution.
Headache Diagnosis and Testing in Headache in Adults I course,
American Academy of Neurology, Philadelphia, PA, May 11, 2001.
Original Syllabus contribution.
How Pathophysiology Explains the Clinical Features of Migraine, Dealing
with Headaches in the Real World course, Beth Israel Medical Center and
St. Luke’s-Roosevelt Hospital Center, NY, NY June 1, 2001. Original
Syllabus contribution.
11
The Triptans: New Clinical Endpoints in Evaluating differences in
Triptans for Patient Care. The 15th Italian Society for the Study of
Headache, Florence, Italy, June 11, 2001. Original Syllabus contribution.
Acute Treatment of Migraine: Issues of Disability and Early Intervention.
The 15th Italian Society for the Study of Headache, Florence, Italy, June
12, 2001. Original Syllabus contribution.
HIT-6 Scores Discriminate Among Headache Sufferers Differing in
Headache-Associated Workplace Productivity Loss. Platform
presentation, World Congress of Neurology, London, UK, June 18, 2001.
Migraine- A Summary. For Japanese General Neurologists at World
Congress of Neurology, London, UK, June 19, 2001.
HIT-6 Reliably Measures the Impact of Headache. Platform presentation,
World Congress of Neurology, London, UK, June 19, 2001.
Impact of Migraine Relative to Other Headache Types. Platform
presentation, International Headache Congress, NY, NY, June 27- July 1,
2001.
Co-prescription of triptans with other medications: a cohort study
involving 240,268 patients. Poster Platform Discussion, International
Headache Research Symposium, Copenhagen, Denmark, Nov 30- Dec 1,
2001
Tension Headache and Migraine, Symposium, Winter course, American
Headache Society Symposium, Bal Harbour, Fla, Jan 2002. Original
Syllabus contribution.
Acute Treatment Options, Migraine Symposium, Winter course, American
Headache Society, Bal Harbour, Fla, Jan 2002. Original Syllabus
contribution.
Neurologic Examination of the Headache Patient. Headache Cooperative
of New England winter course. Stowe, VT, March 2002.
Analgesics and Other Frequently Used Medications are a Cause, Not a
Consequence of Chronic Daily Headache, Debate, Winter course,
American Headache Society, Bal Harbour, Fla, Jan 2002. Original
Syllabus contribution and subsequent invited article in Headache.
Efficacy of Oral Zolmitriptan 2.5 mg in Mild, Moderate, and Severe
Migraine: Results of Treating More than 20,000 Attacks. Platform
12
presentation, American Academy of Neurology, Denver, Colorado, Apr 18,
2002.
Sensitivity of Headache Impact Test (HIT) in Distinguishing Headache
Impact among Headache Sufferers Receiving Pharmacological Treatment.
Platform presentation, American Academy of Neurology, Denver,
Colorado, Apr 18, 2002.
New Advances and Understandings in the Diagnosis and Care of Migraine
Patients, Presentations of Migraine. Symposium, American Headache
Society meeting, Seattle, WA June 21, 2002.
Advancing the Knowledge of Migraine Therapy, Prevalence of Migraine
in General Practice. Chairman and lecture, Symposium, European
Headache Federation, Istanbul, Turkey, June 27, 2002.
Co-prescription of triptans with other medications: a cohort study
involving 240,268 patients. Platform presentation at the American
Headache Society meeting, Seattle, WA, June 21, 2002
Co-prescription of triptans with other medications: a cohort study
involving 240,268 patients. Platform presentation 6th Congress of the
European Headache Federation, Istanbul, Turkey, June 28, 2002.
Value of Delivering Health Status Assessment Via the Internet. Platform
presentation at the 6th Congress of the European Headache Federation,
Istanbul, Turkey, June 29, 2002.
Broadening the Spectrum of Efficacy. Symposium, Tokyo, Japan, Sept 14,
2002.
Advancing the Diagnosis and Treatment of Migraine, Prevalence and
Diagnosis of Migraine in General Practice. Chairman and lecture,
Symposium, for the 14th Migraine Trust International Symposium,
London, UK, Sept 24, 2002.
Expert Panel Review of Patient Diary Data Using IHS Classification. 14th
Migraine Trust International Symposium, Poster Platform presentation,
London, UK, Sept 25, 2002.
Prevalence and Diagnosis of Migraine in a Primary Care Setting- Data
from the Landmark Study. Platform Presentation, European Federation of
Neurologic Societies meeting, Vienna, Austria, Oct 29, 2002.
13
Association of Headache Impact Test (HIT-6) and IHS Migraine
Diagnosis in the Primary Care Setting. European Federation of
Neurologic Societies, Vienna, Austria, Oct 28-30, 2002.
Reduced Headache Impact with Sumatriptan in the Primary Care Setting.
Platform Presentaion, European Federation of Neurologic Societies
meeting, Vienna, Austria, Oct 29, 2002.
Meta-analyses: Are they useful in clinical decision making? Con. Debate,
American Headache Society Headache Symposium, Scottsdale, AZ. Nov
16, 2002.
Meet the Professor Breakfast Symposium, Headaches. American College
of Allergy, Asthma, and Immunology. San Antonio, TX. Nov 17, 2002.
New Thoughts on “Sinus Headaches”. Plenary Session: Controversies in
Sinusitis. American College of Allergy, Asthma, and Immunology. San
Antonio, TX. Nov 17, 2002.
Thoughts on Clinical Management of Chronic Daily Headache and
Rebound Headache in the Office. Headache Cooperative of New England,
winter course. Stowe, VT, March 1, 2003. Original Syllabus contribution.
Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM. Botulinum Toxin in the
Preventive Treatment of Refractory Headaches. Platform Poster
presentation, International Headache Research Seminars, Copenhagen,
Denmark March 2003.
Future Therapeutic Targets: Beyond Triptans, for Headache In Adults I,
course at American Academy of Neurology, Apr 4, 2003. Original Syllabus
contribution.
Role of Analgesics in Intractable and Chronic Daily Headache, for
Intractable Headaches, course at American Academy of Neurology, Apr 4,
2003. Original Syllabus contribution.
Botulinum Toxin in the Preventive Treatment of Refractory Headaches.
Platform presentation, American Academy of Neurology, Honolulu,
Hawaii, April 2003.
Naratriptan in the Preventive Treatment of Refractory Chronic Migraine.
Platform Presentation, American Academy of Neurology, Honolulu,
Hawaii, April 2003.
“Sinus Headaches” and Migraine- Diagnostic Issues. Eastern Allergy
Society, Palm Beach, Fl, May, 2003. Original Syllabus contribution.
14
New Thoughts on “Sinus Headache”. New England Allergy Society
meeting, Portsmouth, NH, Oct, 2003. Original Syllabus contribution.
Understanding the New IHS Criteria. in The New IHS Criteria and
Emerging Uses of Long-acting Triptans, CME symposium American
Headache Society meeting, Scottsdale, AZ, Nov 15, 2003.
How to Identify Migraine in a Primary Care Setting, Osaka, Japan and
Tokyo, Japan, Nov 20 and Nov 27, 2003.
Moderator: Scientific Sessions, American Academy of Neurology, 2001,
2002, 2003: Prepared questions and led platform discussion.
Moderator: National Headache Foundation, 1st Annual Research
Symposium, Palm Springs, CA, Feb 2004: Reviewed and selected
submissions and prepared questions and led platform discussion.
Prevalence and Demographics of Migrainous Headache Adults in a
Primary Care Setting: Data from the Landmark Study, National Headache
Foundation 1st Annual Research Symposium, Rancho Mirage, CA, Feb 10,
2004.
Drug Interactions, The 17th Annual Practicing Physician’s Approach to the
Difficult Headache Patient, National Headache Foundation, Rancho
Mirage, CA, Feb 12, 2004. Original Syllabus contribution.
Diagnostic Challenges in Identifying Migraine, and Acute Treatment of
Migraine, Tokyo, Japan, Feb 21, 2004.
Preventive Therapy of Migraine. Headache Cooperative of New England,
winter course. Stowe, VT. March 2004. Original Syllabus contribution.
The New 2004 IHS Classification System: Preliminary Introduction.
American Headache Society CME symposium, June 2004.
The New 2004 IHS Classification System: Chronic Daily Headache.
American Headache Society June 2004. Original Syllabus contribution.
Drug Interactions in Headache Management, National Headache
Foundation Headache Update 2004, Orlando, Fl, July 15, 2004. Original
Syllabus contribution.
Preventive Therapy of Migraine, National Headache Foundation
Headache Update 2004, July 17, 2004. Original Syllabus contribution.
15
New Thoughts on “Sinus Headache”, 10th Annual Summer Allergy
Conference, Albany (NY) Medical College, Saratoga, NY, July 22, 2004.
Original Syllabus contribution.
Preventive Therapies- Consensus for Guideline Recommendations.
Headache Care for Practicing Clinicians. Lisbon, Portugal, Oct 1, 2004.
Original Syllabus contribution and invited article, Headache Care.
The Migraine Assessment of Current Therapy (Migraine-ACT)
questionnaire: further investigation of study methodology and results.
Platform presentation, Headache Care for Practicing Clinicians, Lisbon,
Portugal, Oct 1-2, 2004.
How to Identify and Treat Headache in a Primary Care Setting. Kobe and
Kyoto, Japan, Oct 27-28, 2004.
Headache Diagnosis in 15 minutes or Less. Headache Cooperative of New
England course, Boston, MA, Nov 6, 2004. Original Syllabus
contribution.
Herbs, Minerals, Vitamins, and Supplements. American Headache
Society, Scottsdale, AZ. Nov 13, 2004. Original Syllabus contribution.
5 Papers that will change your clinical practice: The Chronic Daily
Headache studies of Dr. Ann Scher. American Headache Society,
Scottsdale, AZ. Nov 13, 2004. Original Syllabus contribution.
Moderator: American Headache Society, Scottsdale, AZ Nov 2004.
Prepared questions and led platform discussion.
Pathophysiology of Migraine and Future Targets Beyond Triptans, 24th
Annual US Army Medical Department Neurology Education course
(AMEDD), Washington, DC. Nov 16, 2004. Original Syllabus
contribution.
American Headache Society Neurology Ambassador Program Core
Faculty, 2000-2004.
Chronic Daily Headache. Grand Rounds, Allegheny Medical Center, and
Shadyside Hospital, Pittsburgh PA. Feb 2-3,2005.
New Options in Migraine Management. Neurological Diseases in 2005:
Medical and Surgical Options. Cedars-Sinai Medical Center CME course,
San Diego, CA. Feb 18, 2005. Original Syllabus contribution.
16
The Five Best Papers of 2004: Papers that will change your practice.
Headache Cooperative of New England Winter Meeting. Stowe, VT.
March 5, 2005. Original Syllabus contribution.
The Landmark Study: What type of Episodic Headache Really comes into
the Primary Care Office Worldwide. 5th National Multidisciplinary
Formation Course on Headache, SISC (Italian Headache Society). Capri,
Italy. Apr 1, 2005. Original Syllabus contribution.
Migraine is Not Usually A Progressive Disorder. Debates in Headache
Course, with Dr. Richard Lipton. Joel Saper, MD, Chairman. American
Academy of Neurology, Miami, Fl. Apr 12, 2005.
Chronic Daily Headache. Medicine Grand Rounds, Borgess Medical
Center, Kalamazoo, MI. Apr 15, 2005.
New Thoughts in Diagnosis of Migraine. Medicine Grand Rounds, Our
Lady of Mercy Medical Center. The Bronx, NY. Apr 20, 2005.
Pathophysiology of Migraine. Neurology Grand Rounds, University of
Wisconsin. Madison, WI. Apr 29, 2005.
Chronic Daily Headache. Neurology Grand Rounds. St Mary’s Hospital,
Madison, WI. Apr 29, 2005.
The Global Migraine Burden: Socio-economic Impact. Presented at the
Migraine Metaforum, European Consensus Conference on Migraine.
Migraine: The Forgotten Epidemic: A European Perspective. Sponsored
by the European Headache Federation and University of Duisburg/Essen.
Rome, Italy. June 10, 2005.
Pathophysiology of Migraine. Neurology Grand Rounds. NY Medical
College. Valhalla, NY. June 14, 2005.
New Thoughts on Diagnosis of Migraine. Family Practice Noon
Conference, St Francis Hospital. Indianapolis, IN. Aug 4, 2005.
Chronic Daily Headache. Neurology Noon Conference. Albert Einstein
Medical Center, Philadelphia, PA. Sept 9, 2005.
Case Studies in Headache. NPACE Nurse Practitioners Midwestern CME
Course. Chicago, Ill. Sept 13, 2005. Original Syllabus contribution.
Findings from the Landmark Study, and the Importance of Targeted
Treatment. , in the symposium Is it a Migraine? What Every Woman
17
Needs to Know. Society for Women’s Health Research. NY, NY. Sept 28,
2005.
Herbs, Minerals, Vitamins and Supplements in Headache. Headache Care
for Practicing Clinicians, London, UK, Oct 29, 2005. Original Syllabus
contribution.
Controversies in IHS ICHD-II Nomenclature. Headache Care for
Practicing Clinicians, London, UK, Oct 29, 2005. Original Syllabus
contribution.
Case Studies in Headache. NPACE Nurse Practitioners Eastern CME
Course. Boston, MA, Nov 2, 2005. Original Syllabus contribution.
Multimodal Migraine Therapy, Montefiore-Albert Einstein School of
Medicine Neurology CME course, NY, NY, Nov 4, 2005. Original
Syllabus contribution.
Avoiding Medical and Legal Pitfalls in the Office Diagnosis of Headache.
Headache Cooperative of New England Spotlight on New and Emerging
Headache Treatments CME course, Nov 12, 2005. Original Syllabus
contribution.
Herbs, Minerals, Vitamins and Supplements in the Headache Use Today.
American Headache Society Scottsdale Symposium, Scottsdale, AZ, Nov
19-20, 2005. Original Syllabus contribution.
Navigating the ICHD-II Diagnostic Criteria: Clinical Cases. American
Headache Society Scottsdale Symposium, Scottsdale, AZ, Nov 19-20,
2005. Original Syllabus contribution.
Work-up of the Headache Patient: What’s Appropriate? American
Headache Society Winter Symposium Las Vegas, NV, Jan. 27, 2006.
Original Syllabus contribution.
Case Discussions and Chronic Daily Headache. American Headache
Society Winter Symposium Las Vegas, NV, Jan. 27, 2006. Clinical cases
prepared and presented.
New Thoughts About Sinus Headache. The 15th Annual [CME] Education
Symposium of the Allergy, Asthma, and Immunology Foundation of
Northern California. “Controversies in Asthma and Allergies”, San
Francisco, CA, Feb 11, 2006. Original Syllabus contribution.
Diagnosing Headache: Tools and Strategies for the Busy Clinician.
Misdiagnosed, Misunderstood: Effective Strategies for Differentiating
Headache. CME Session, The 19th Annual Practicing Physician’s
18
Approach to the Difficult Headache Patient, National Headache
Foundation, Rancho Mirage, CA, Feb 16, 2006. Original Syllabus
contribution.
High and Low Pressure Headaches. CME, The 16th Annual Headache
Symposium, Headache Cooperative of New England, Stowe, VT March 4,
2006. Original Syllabus contribution.
Debates in Headache: The Case Against Chronic Opioids for Chronic
Daily Headache. CME course, 58th Annual Meeting, American Academy
of Neurology, Apr 7, 2006.
Chronic Daily Headache, CME course. Neuroscience Update for Primary
Care Practitioners, Ellis Hospital Neurosciences. Scotia, NY, May 4,
2006.
Alternative Treatment: Herbs, Minerals, Vitamins and Supplements. CME
course, 21st Century Neurology, Florida Association for the Study of
Headache and Neurological Disorders. Palm Beach Gardens, FL, May 11,
2006.
Migraine Pathophysiology and Drug Action. CME course, The Changing
Face of Migraine Treatment. Diamond Headache Update 2006. Orlando,
FL, July 13, 2006.
Stopping migraines before they occur. CME course, The Sixth Annural
Headache Cooperative of New England Boston Headache Symposium.
Boston, MA. Nov 4, 2006. Original Syllabus contribution.
Preventive Treatment of Headache. CME course, The 17th Annual
Headache Symposium, Headache Cooperative of New England, Stowe,
VT March 2, 2007. Original Syllabus contribution.
Diagnosis and Treatment Options for Migraine. CME, given in Hamilton
and Toronto, Ontario, Canada, March 28-29, 2007.
Pathophysiology of Migraine: Link to Acute Treatment. CME, the Wasser
Pain Clinic, Toronto, Ontario, Canada, March 28, 2007 and Kingston
General Hospital Neurology Grand Rounds, Kingston, Ontario, Canada,
March 29, 2007.
PFO and Migraine. CME, Ottawa Hospital Neurology Grand Rounds,
Ottawa, Canada, March 30, 2007.
Current Approach to Menstrual Migraine and Short-term Prevention:
Evidence and Evolving Preventive Treatment Models, in Expanding the
19
Boundaries of Migraine Management: A Focus on Menstrual Migriane,
CME Symposium, Academy of Managed Care Pharmacies, San Diego,
CA, Apr 12, 2007.
PFO and Migraine. Focus on Primary Headaches: Recent Advances in
Mechanisms and Management, ANIRCEF, Stresa, Italy, May 25, 2007.
Original Syllabus contribution and published article.
Post-traumatic headaches and headaches attributed to vascular disorders.
Headache Medicine Subspecialty CME Examination Review Course,
American Headache Society 49th Annual Scientific Meeting, Chicago, Ill,
June 6, 2007. Original Syllabus contribution.
CGRP Antagonists: Clinical Trials and Potential Implications for Clinical
Practice. The Role of CGRP in Migraine Therapy, CME Symposium,
American Headache Society 49th Annual Scientific Meeting, Chicago, Ill,
June 8, 2007. Original Syllabus contribution.
Headache Attributed to Head and/or Neck Injury. Neurology Grand
Rounds, Rhode Island Hospital, Brown University School of Medicine,
Providence, RI, July 18, 2007.
The Future of Acute Treatment of Migraine. Neurology Grand Rounds,
Virginia Commonwealth University (Medical College of Virginia),
Richmond, VA, Sept 13, 2007.
Optimal Acute Treatment of Migraine. Grand Rounds, Mary Washington
Hospital, Fredericksberg, VA, Sept 14, 2007.
Acute Treatment of Migraine. Grand Rounds, St Lukes Hospital, Boise,
Idaho, Oct 10, 2007.
Acute Treatment of Migraine. Grand Rounds, Mercy Hospital, Nampa,
Idaho, Oct 10, 2007.
Acute Treatment of Migraine. Grand Rounds, West Valley Medical
Center, Caldwell, Idaho, Oct 11, 2007.
Serotonin Syndrome. American Headache Society meeting, Phoenix, AZ,
Nov 2, 2007. Original Syllabus contribution.
Osteopathic and Chiropractic Treatment of Headache: Evidence-Based
Medicine Assessment. American Headache Society meeting, Phoenix, AZ,
Nov 2, 2007. Original Syllabus contribution.
Pathophysiology of Migraine. Tufts-New England Medical Center Pain
Center, Dec 12, 2007.
20
Acute Treatment of Migraine. Neurology Grand Rounds, Walter Reed
Army Medical Center, Washington, DC, Jan 16, 2008.
Acute Treatment of Migraine. Neurology Grand Rounds, Georgetown
University School of Medicine, Washington, DC, Jan 16, 2008.
Headache and Migraine: Evaluation, Management, and When to Refer.
Cedars Sinai CME Course, Marina Del Rey, CA, Feb 16, 2008.
Protocols for Medication Overuse Headache, Headache Cooperative of
New England 18th Annual Headache Symposium, Feb 29, 2008.
Patent Foramen Ovale and Migraine. Neurology Grand Rounds, Cleveland
Clinic, Cleveland, OH, March 17, 2008.
PFO and Migraine: Suggested Mechanisms, in Structural Heart Disease:
Mechanisms and Mysteries Course, Society for Cardiovascular
Angiography and Interventions, American College of Cardiology meeting,
Chicago, Apr 1, 2008.
Outpatient Headache Therapy, in Headache Therapy, CME course, 60th
annual meeting American Academy of Neurology, Chicago, April 18,
2008. Original syllabus contribution.
Should Triptans be Available Over-the Counter in the United States? In
Debates in Headache, CME course, 60th annual meeting, American
Academy of Neurology, Chicago, April 18, 2008.
Patent Foramen Ovale and Migraine. Medicine CME Grand Rounds,
Allegheny Medical Center, Pittsburgh, PA, Apr 30, 2008.
Patent Foramen Ovale and Migraine. Neurology CME Grand Rounds,
University of Pittsburgh Medical Center, Pittsburgh, PA, Apr 30, 2008.
Chronic Migraine and Medication Overuse Headache. Update in
Headache Management, CME course, Cleveland Clinic Center for
Headache and Pain and the Ohio Headache Association, Cleveland, OH,
May 30, 2008. Original syllabus contribution.
CGRP Receptor Antagonists- Targeting Acute Migraine Treatment, in
CME Course, New Neuronal Targets In Migraine Therapy: What Does the
Future Hold? American Headache Society meeting, Boston, MA, June 28,
2008. Original syllabus contribution.
21
Migraine: Epidemiology and Diagnosis. Cleveland Clinic Neurology
Residents Noon Conference, Oct 21, 2008.
Migraine: Pathophysiology. Cleveland Clinic Neurology Residents Noon
Conference, Oct 22, 2008.
Migraine: Acute and Preventive Treatment. Cleveland Clinic Neurology
Residents Noon Conference, Oct 27, 2008.
Trigeminal Autonomic Cephalalgias and Hemicrania Continua. Cleveland
Clinic Neurology Residents Noon Conference, Oct 28, 2008.
Herbs, Minerals, Vitamins, and Supplements: Randomized Controlled
Trials and Evidence-based Recommendations for Use in Headache.
American Headache Society Scottsdale CME Symposium, Scottsdale, AZ,
Nov 6, 2008. Original Syllabus Contribution.
Preventive Migraine Treatment. American Headache Society Scottsdale
CME Symposium, Scottsdale, AZ, Nov 7, 2008. Original Syllabus
Contribution.
Drug-drug Interactions in Headache. American Headache Society
Scottsdale CME Symposium, Scottsdale, AZ, Nov 8, 2008. Original
Syllabus Contribution.
Epidemiology of Headaches. 1st International Headache CME Summit.
Tel Aviv, Israel, November 14, 2008.
Debate: Prognosis of Migraine: Is it a potentially serious disorder in some
patients? 1st International Headache CME Summit. Tel Aviv, Israel,
November 14, 2008.
Treatment of Refractory Headache Patients. 1st International Headache
CME Summit. Tel Aviv, Israel, November 16, 2008.
Taking the Headache out of Migraine Diagnosis and Treatment. PRIMED
CME. Original syllabus contribution. Seattle, WA Sept 26, 2008; New
York City, Oct 2, 2008; Tampa, FL Dec 4, 2008.
Drug-Drug Interactions in Migraine Treatment. Combined Pain Medicine
Grand Rounds. Cleveland Clinic, March 24, 2009.
Acute Treatment of Migraine. Headache Therapy course, American
Academy of Neurology, May 1, 2009.
22
Pharmacologic Prevention of Migraine. Pain Medicine Grand Rounds,
Cleveland Clinic, May 4, 2009.
Overview of Migraine. Hospital Grand Rounds, Lakewood Hospital,
Lakewood, OH, May 5, 2009.
Herbs, minerals, vitamins and supplements in headache. Florida
Association for the Study of Headache, West Palm Beach, FL, May 16,
2009.
Acute Migraine Treatment – Current and Future. IXth Colombian
Congress of Neurology, Santa Marta, Colombia, Aug 15, 2009.
Preventive Migraine Treatment- Current and Future. IXth Colombian
Congress of Neurology, Santa Marta, Colombia, Aug 15, 2009.
Meeting diverse acute migraine treatment needs through novel treatment
formulations. CME Satellite Symposium, 14th International Headache
Congress, Philadelphia, PA, Sept 12, 2009.
Migraine Overview. The 12th National Chinese Conference of Neurology,
Beijing, China Oct 16, 2009.
Overview of Acute and Preventive Treatments of Migraine and Primary
Headaches. The 12th National Chinese Conference of Neurology, Beijing,
China Oct 18, 2009.
Trigeminal Autonomic Cephalalgias and Other Primary Headaches. With
Dr. Lawrence Newman, 2009 Scottsdale Headache Symposium, American
Headache Society, Scottsdale, AZ, Nov 6. 2009. Original CME Syllabus
submission.
Diagnosis of Chronic Daily Headache. 2009 Scottsdale Headache
Symposium, American Headache Society, Nov 6. 2009 Scottsdale, AZ.
Original CME Syllabus submission.
Sphenopalatine (SPG) and Other Stimulation for Headaches. North
American Neuromodulation Society Meeting, Las Vegas, NV, Dec 5,
2009. Original CME Syllabus submission.
Epidemiology and Diagnosis of Migraine. Cleveland Clinic Neurology
Residents Noon Conference, Jan 26, 2010.
Pathophysiology of Migraine. Cleveland Clinic Neurology Residents
Noon Conference, Feb 3, 2010.
23
Latest Advances in Rescue and Prevention therapy for Migraine. 4th
Annual Advances in Neurology and Neurosurgery Symposium, CedarsSinai Medical Center, February 20, 2010, Marina Del Rey, CA. Original
CME submission.
Acute Treatment of Migraine. Cleveland Clinic Neurology Residents
Noon Conference, March 17, 2010.
Trigeminal Autonomic Cephalalgias and Hemicrania Continua. Cleveland
Clinic Neurology Residents Noon Conference, Apr 6, 2010.
What Do I Do Now? In Headache Therapy Course, American Academy of
Neurology, Toronto, Ontario, Apr 16, 2009. Original CME submission.
Brain Changes and Medication Overuse Headache. In Hot Topics in
Headache course, American Academy of Neurology, Toronto, Ontario, Apr
17, 2009. Original CME submission.
Medication Overuse Headache. Cleveland Clinic Neurology Residents
Noon Conference, May 13, 2010.
Pathophysiology and Genesis of Medication Overuse Headache. In Update
in Headache Management course, Ohio Headache Association/Cleveland
Clinic, Cleveland, Ohio, May 14, 2010. Original CME submission.
Pathophysiology of Migraine. In Update in Headache Management course,
Ohio Headache Association/Cleveland Clinic, Cleveland, Ohio, May 15,
2010. Original CME submission.
Future Treatment of Migraine. In Update in Headache Management
course, Ohio Headache Association/Cleveland Clinic, Cleveland, Ohio,
May 15, 2010. Original CME submission.
The International Classification of Headache Disorders, 2d Edition and
Diagnosis of Migraine, its variants, and Tension-type Headache.
Cleveland Clinic Neurology Residents Noon Conference, Aug 13, 2010.
Trigeminal Autonomic Cephalalgias. Cleveland Clinic Neurology
Residents Noon Conference, Aug 18, 2010.
Prevention of Migraine. Cleveland Clinic Neurology Residents Noon
Conference, Sept 22, 2010.
Acute Treatment of Migraine. Cleveland Clinic Neurology Residents
Noon Conference, Nov 10, 2010 & March 8, 2011.
24
TACs and Other Primary Headache Syndromes- How We Do it. 2010
Scottsdale Headache Symposium, American Headache Society. Original
CME submission, Nov 19, 2010.
Chronic Migraine, MOH: Here’s What We Do/Detox. 2010 Scottsdale
Headache Symposium, American Headache Society. Original CME
submission, Nov 20, 2010.
Acute Treatment of Migraine. 24th Annual Practicing Physican’s
Approach to the Difficult Headache Patient. Rancho Mirage, CA, Feb 20,
2011. Original CME submission.
Overview of Migraine, Acute and Preventive Treatment, Cleveland Clinic
Department of Internal Medicine CME course, Cleveland, OH, Feb 25,
2011.
Chronic Daily Headache, In Headache In Adults course, American
Academy of Neurology Apr 10, 2011. Original CME submission.
Utility of LEVADEX (MAP0004) in Situations Where Early Intervention
Paradigm Is Impractical. American Academy of Neurology Honolulu, HI,
Apr 12, 2011.
Acute Treatment of Migraine. In Headache Therapy course, American
Academy of Neurology Honolulu, HI, Apr 14, 2011.
Migraine. Cleveland Clinic Department of Internal Medicine CME course,
Cleveland, OH, May 11, 2011.
Non-migrainous Headaches: Secondary Sinister Headaches, Chronic Daily
Headache, Trigeminal Autonomic Cephalalgias, and Other Primary
Headaches. Cleveland Clinic Department of Internal Medicine CME
course, Cleveland, OH, May 11, 2011.
Pathophysiology of Medication Overuse Headache. Ohio Headache
Association, Columbus, OH, May 13, 2011.
The IDE for SPG Stimulation for Episodic Migraine: IRB 10-081:
Electrical Stimulation of the Sphenopalatine Ganglion for the Treatment
of Migraine Headaches, ATI Scientific Advisory Board, American
Headache Society Scientific Meeting, June 1, 2011.
Sinister Secondary Headaches, Cleveland Clinic Neurology Residents
Noon Conference, July 22, 2011.
25
Thomas H. Mason Memorial Invited Guest CME Lecture: Taking the
Headache Out of Migraine Diagnosis and Management. Neuroscience
Update for Primary Care Practitioners. EllisMedicine, Scotia, New York
October 20, 2011.
Expert Opinion: Discuss Your Most Difficult Cases. Challenges in
Headache Medicine. Southern Headache Society, Asheville, NC, Oct 22,
2011.
The use of opiates in headache: A debate. Southern Headache Society,
Asheville, NC, Oct 23, 2011.
Advanced Interventions for Headache. Southern Headache Society,
Asheville, NC, Oct 23, 2011.
TACs and Other Primary Headaches. 2011 Scottsdale Headache
Symposium, American Headache Society. Original CME submission, Nov
11, 2011.
Chronic Migraine, MOH Pharmaceutical Protocols. 2011 Scottsdale
Headache Symposium, American Headache Society. Original CME
submission, Nov 12, 2011.
Pathophysiology of Migraine. Cleveland Clinic Neurology Residents
Noon Conference, Nov 16, 2011.
Acute Treatment of Migraine. Cleveland Clinic Neurology Residents
Noon Conference, Jan 25, 2012.
Trigeminal Autonomic Cephalalgias –Cluster and Paroxysmal
Hemicrania. Cleveland Clinic Neurology Residents Noon Conference,
Apr 11, 2012.
Chronic Migraine and the Role for Botulinum Toxins, in the Cleveland
Clinic Second Current and Emerging Uses of Botulinum Toxins in
Neurology and Rehabilitation: A Practical Skills Workshop (CME),
Birmingham, MI, June 9, 2012
Sinister Secondary Headaches. Cleveland Clinic Neurology Residents
Noon Conference, July 25, 2012.
Headache Update: Migraines and Beyond, in 2012 Neurology Update- A
Comprehensive Review for the Clinician, Cleveland Clinic CME Course,
Washington, DC, Aug 3, 2012.
26
Chronic Migraine, Chronic Daily Headache and Medication Overuse
Headache, in 2012 Neurology Update- A Comprehensive Review for the
Clinician, Cleveland Clinic CME Course, Washington, DC, Aug 3, 2012.
Chronic Migraine and Medication Overuse Headache, in The Many Faces
of Migraine, Ohio Headache Association CME course, Cincinnati, OH,
Sept 7, 2012.
Procedural Management of Headaches, in Sixth Annual CME
Commonwealth Neurological Society Fall Meeting, Louisville, KY, Sept
15, 2012.
Medication Overuse Headache, in Frontiers in Neuromuscular Disease and
Neuro-Rehabilitation, Case Western Reserve University and the Louis
Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, Oct
18, 2012.
TACS and Other Primary Headaches, American Headache Society
Scottsdale Headache Symposium, Scottsdale, AZ, Original CME
submission, Nov 16, 2012.
Chronic Migraine: Treatment and Protocols, American Headache Society
Scottsdale Headache Symposium, Scottsdale, AZ, Original CME
submission, Nov 17, 2012.
Serotonin Syndrome and Headache Treatment. Maryland Headache
Society, Baltimore, MD, Nov 27, 2012.
Serotonin Syndrome and Headache Treatment. CME Neurology Grand
Rounds, Cleveland Clinic, Dec 10, 2012.
Chronic Daily Headache, Chronic Migraine, and Medication Overuse
Headache. CME Neurology Grand Rounds, Cleveland Clinic, Feb 4, 2013.
Opioids and Migraine. CME 15th Annual Cleveland Clinic Pain
Management Symposium, Sarasota, FL, Feb 20, 2013.
Medication Overuse Headache. CME 15th Annual Cleveland Clinic Pain
Management Symposium, Sarasota, FL, Feb 20, 2013.
Treatment of Migraine. Cleveland Clinic Pain Management Didactic
Lecture, Cleveland Clinic, Mar 4, 2013
Trigeminal Autonomic Cephalalgias. New York University School of
Medicine Neurology Grand Rounds, NY, NY, Mar 12, 2013.
27
Acute Treatment of Migraine. In Therapy of Headache CME course,
American Academy of Neurology, San Diego, CA, Mar 16, 2013.
Medication Overuse Headache. Cleveland Clinic Pain Management
Didactic Lecture, Cleveland Clinic, May 6, 2013
International Classification of the Headaches: What´s new. 50th
Dominican Republic Neurological Society Annual Meeting, Punta Cana,
Dominican Republic, June 1, 2013.
Headaches: New Therapies. 50th Dominican Republic Neurological
Society Annual Meeting, Punta Cana, Dominican Republic, June 1, 2013.
Migraine Physiopathology. 50th Dominican Republic Neurological
Society Annual Meeting, Punta Cana, Dominican Republic, June 1, 2013.
Should Randomized Clinical Trials be used in Clinical Practice? In the
CME course, Controversies in Headache, International Headache
Congress, Boston, MA, June 27, 2013.
Migraine Pathophysiology in Practice. In Product Theater, International
Headache Congress, Boston, MA, June 29, 2013
Sinister Headaches. Cleveland Clinic Neurology Residents Noon
Conference, July 19, 2013.
Migraine Update. In 2013 Neurology Update- A Comprehensive Review
for the Clinician, Cleveland Clinic CME course, Original syllabus
contribution, Washington, DC, August 3, 2013.
Chronic Migraine and Medication Overuse Headache. In 2013 Neurology
Update- A Comprehensive Review for the Clinician, Cleveland Clinic
CME course, Original syllabus contribution, Washington, DC, August 3,
2013.
Pathophysiology of Primary Headaches- What is New? In What is New in
Headache – 2013, International Headache Society course, Mumbai, India,
August 11, 2013.
Chronic Migraine- The Evolution, The Diagnostic Challenges. In What is
New in Headache – 2013, International Headache Society course,
Mumbai, India, August 11, 2013.
Migraine Treatment in 2013- Paradigms That Have Changed. In What is
New in Headache – 2013, International Headache Society course,
Mumbai, India, August 11, 2013.
28
Chronic Migraine and Medication Overuse Headache. South Carolina
Neurological Society Annual Meeting, CME, Charleston, SC, Oct 5, 2012.
OnabotulinumtoxinA and Chronic Migraine. Morning Conference,
Physical Medicine and Rehabilitation and Neurology Residency programs,
The Ohio State University Wexner Medical Center, Columbus, Ohio, Oct
7, 2013.
Protocols for Medication Overuse Headache and Chronic Migraine. 2013
American Headache Society Scottsdale Headache Symposium. CME,
Scottsdale, AZ, Nov 23, 2013.
Sphenopalatine Ganglion Stimulation, Deep Brain Stimulation, Hand-held
Vagal Nerve Stimulation, Transcranial Magnetic Stimulation. 2013
American Headache Society Scottsdale Headache Symposium. CME,
Scottsdale, AZ, Nov 23, 2013.
Neuromodulation for Migraine. 17th Annual North American
Neuromodulation Society meeting. CME, Las Vegas, NV, Dec 7, 2013.
Advances in Cluster Headache Management. 17th Annual North American
Neuromodulation Society meeting. CME, Las Vegas, NV, Dec 7, 2013.
Chronic Daily Headache, Chronic Migraine, and Medication Overuse
Headache. Neurology Grand Rounds, Michigan State University College
of Human Medicine, East Lansing, MI, Dec 13, 2013.
Chronic Daily Headache, Chronic Migraine, and Medication Overuse
Headache. CME Neurosurgery Grand Rounds, Cleveland Clinic, Jan 15,
2014.
Trigeminal Autonomic Cephalalgias. Cleveland Clinic Neurology
Residents Noon Conference, Jan 17, 2014.
Chronic Daily Headache, Chronic Migraine, and Medication Overuse
Headache. CME Neurology Grand Rounds, University of Maryland
School of Medicine, Baltimore, MD, March 5, 2014.
Neuromodulation for Headache: What is the Evidence? CME Headache
Cooperative of New England, Stowe, VT, March 8, 2014.
Current Treatments Delivered Differently. CME 56th Annual American
Headache Scientific Meeting, Los Angeles, CA, June 29, 2014.
29
The Scourge of Frequent Headaches: Practical and Effective Approaches
for Diagnosis and Treatment of Chronic Migraine, Chronic Daily
Headache, and Medication Overuse Headache. Mercy St Anne Hospital
Evening CME Program. Toledo, OH, July 29, 2014.
Management of Chronic Daily Headache. 2014 Cleveland Clinic
Neurology Update. Washington, DC, August 2, 2014.
Migraine Update. 2014 Cleveland Clinic CME Neurology Update.
Washington, DC, August 2, 2014.
Serotonin Syndrome and Headache Treatment. Stanley Wissman
Neuroscience/Brain Injury CME Symposium, Manchester University
College of Pharmacy. Fort Wayne, IN, Oct 30, 2014.
Diagnosing Migraine. American Headache Society Comprehensive
Migraine Education CME Program, San Diego, IN, Nov 8, 2014.
Case Studies in Headache. American Headache Society Comprehensive
Migraine Education CME Program, San Diego, IN, Nov 8, 2014.
Preceptorship in Procedures for Headache (Peripheral Nerve Blocks and
Neurotoxin). American Headache Society Comprehensive Migraine
Education CME Program, San Diego, IN, Nov 8, 2014.
Sphenopalatine Ganglion Neuromodulation and Headache. North Central
Headache Society meeting (formerly Ohio Headache Association). New
Albany, OH, Dec 6, 2014.
Neuromodulation and Headache. Headache Cooperative of the Pacific
CME meeting. San Francisco, CA, Jan 16, 2015.
Highlights of the AAN, AHS, and EHMTIC Meetings. Headache
Cooperative of the Pacific CME meeting. San Francisco, CA, Jan 17,
2015.
Chronic Headache: State-of-the-art and Challenging Cases. American
Academy of Neurology Breakthroughs in Neurology CME Conference.
Phoenix, AZ, Jan 24, 2015.
Migraine Therapy: Cutting Edge Innovation. North Carolina Neurological
Society 2015 CME Annual Meeting. Charlotte, NC, Feb 21, 2015.
Neuromodulation and Headache Disorders. University of Louisville
Department of Neurology CME Grand Rounds, Louisville, KY, March 27,
2015.
30
Sphenopalatine Ganglion Stimulation (SPG): Mechanism, Efficacy, and
Safety. CME lecture, 17th International Headache Congress, Valencia,
Spain, May 13, 2015.
Headache Update 2015: New Formulations, Neuromodulation, and
Monoclonal Antibodies. 17th Annual Update in Headache and Pain
Management, CME Annual Course from the Michigan Headpain and
Neurological Institute and Michigan State University, Dearborn, MI, May
29, 2015.
Clinical Case Presentations. 17th Annual Update in Headache and Pain
Management, CME Annual Course from the Michigan Headpain and
Neurological Institute and Michigan State University, Dearborn, MI, May
29, 2015.
Prevention of Migraine/Chronic Migraine. Headache Update 2015,
Diamond Headache Clinic Research & Educational Foundation CME
course, Orlando, FL, July 16, 2015.
Neuromodulation. Headache Update 2015, Diamond Headache Clinic
Research & Educational Foundation CME course, Orlando, FL, July 16,
2015.
Neuromodulation and Headache. 12th Annual Texas Neurological Society
Summer Conference and 5th Annual Southern Headache Society Meeting,
CME Annual Meeting, Fort Worth, TX, Aug 1, 2015.
Headache Update – What is New and What is Approved? Cleveland
Clinic 2015 Neurology Update CME Course, Washington, DC, Aug 8,
2015.
Trigeminal Autonomic Cephalalgias (TACs) and Other Primary
Headaches – Diagnosis and Treatment. Cleveland Clinic 2015 Neurology
Update CME Course, Washington, DC, Aug 8, 2015.
Challenging Cases: Difficult Headache Cases. Cleveland Clinic 2015
Neurology Update CME Course, Washington, DC, Aug 8, 2015.
Neuromodulation and Headache. North Central Headache Society CME
course, Toledo, OH Sept 19, 2015.
31
Computer, multimedia, apps, or Internet-based projects
Therapeutic Management Issues in the Treatment of Headache and
Migraine. Physicians' Teleconference Network, Annenberg Center for
Medical Education, 1995.
Migraine and the New Triptans. Physicians' Teleconference Network,
Annenberg Center for Medical Education, 1998.
Tepper SJ. Tolerability and Safety of the Triptans. Continuing Medical
Education Monograph and Program at www.virtual-headache.com, 2001.
The Landmark Study: Evaluating Diagnosis Patterns in Headache Patients.
CD-Rom; Medical Education Resources, Inc, 2004.
The Expanding Role of Botulinum Neurotoxins in Clinical Practice. CDRom/ I-Pod, Practice Insights 2005.
The Landmark Study. Evaluating Diagnosis Patterns in Headache Patients:
A Pharmacy Perspective. Medical Education Resources, Inc. at
www.pharmacymigraine.com, 2007.
Imitrex RT: The Need for Speed. GSK CD-ROM, 2007.
Migraine. Audio-Digest Neurology; June 21, 2010;1(2).
Pathophysiology and Genesis of Medication Overuse Headache. AudioDigest Neurology; Nov 21,2010;1(12).
Headache and OnabotulinumtoxinA. Presented in Webinar,
CCF Comprehensive Neurotoxin Webinar Series (CME), July 25, 2012.
Headache and OnabotulinumtoxinA. Presented in Webinar,
CCF Comprehensive Neurotoxin Webinar Series (CME), Nov 13, 2013.
OnabotulinumA and Headache Disorders. Presented in Webinar,
CCF Comprehensive Neurotoxin Webinar Series (CME), Oct 29, 2014.
Simple Ways to Help Your Migraine Therapy Work Better. Medscape
CME Video, Sept 2, 2015.
Bringing Migraine Research to Clinical Practice: Practical Expert
Perspectives. Medscape CME Video, Sept 2, 2015.
32
Bibliography
Peer-reviewed original research
Marks LE, Stevens JC, Tepper, SJ. Interaction of Spatial and Temporal
Summation in the Warmth Sense. Sensory Processes. 1976; 1:87-98.
Tepper SJ, Cochran A, Hobbs S, Woessner M. Sumatriptan Suppositories
for the Acute Treatment of Migraine. Int J Clin Pract. 1998; 52:31-35.
Drucker P, Tepper SJ. Daily Sumatriptan for Detoxification from
Rebound. Headache. 1998; 38:687-690.
Tepper SJ, Donnan GA, Dowson AJ, Bomhof MAM, Elkind A, Meloche
J, Tepper S. A long-term study to maximize migraine relief with Zomig.
Current Medical Research and Opinion 1999,15: 254-271.
Mathew NT, Rapoport A, Saper J, Magnus L, Bernstein P, Klapper J,
Ramadan N, Stacey B, Tepper S. Efficacy of Gabapentin in Migraine
Prophylaxis. Headache 2001;41:119-128.
Sheftell FD, Fox AW, Weeks RE, Tepper SJ. Differentiating the efficacy
of 5HT 1B/D Agonists. Headache 2001;41:257-263.
Saper JR, Lake AE, Tepper SJ. Nefazodone for Chronic Daily Headache
Prophylaxis: An Open Label Study. Headache 2001;41:465-474.
Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB. Chronic
Daily Headache: Identification of Factors Associated with Induction and
Transformation. Headache 2002;42:575-581.
Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ. Long-term follow-up of
patients treated for chronic daily headache with analgesic overuse.
Cephalalgia 2002;22:327-328.
Tepper S, Allen C, Sanders D, Greene A, Boccuzzi S. Co-prescription of
triptans with potentially interacting medications: a cohort study involving
240,268 patients. Headache 2003;43:44-48.
Bigal ME, Tepper SJ, Rapoport AM, Sheftell FD. Hemicrania Continua:
Comparison Between Two Different Classification Systems. Cephalalgia
2002;22:242-245.
33
Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium
sulfate in the acute treatment of migraine without aura and migraine with
aura. A randomized, double blind, placebo controlled study. Cephalalgia
2002;22:345-353.
Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftell RB. Chronic
Daily Headache in a Tertiary Care Population. Correlation Between the
International Headache Society Diagnostic Criteria and Proposed
Revisions of Criteria for Chronic Daily Headache. Cephalalgia
2002;22:432-438.
Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous dipyrone in
the acute treatment of migraine without aura and migraine with aura. A
randomized, double blind, placebo controlled study. Headache
2002;42:862-871.
Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Migraine with Aura vs
migraine without Aura: Pain Intensity and Associated Symptoms
Intensities following Placebo. Headache 2002;42:872-877.
Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst
A, Cady R, Dahlof CG, Dowson A, Tepper S. A six-item short-form
survey for measuring headache impact: the HIT-6. Qual Life Res.
2003;12:963-74.
Ware JE Jr, Kosinski M, Bjorner JB, Bayliss MS, Batenhorst A, Dahlof
CG, Tepper S, Dowson A. Applications of computerized adaptive testing
(CAT) to the assessment of headache impact. Qual Life Res. 2003;12:93552.
Antoniazzi AL, Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Headache
and Hemodialysis: A Prospective Study. Headache 2003;43:99-102.
Bjorner JB, Ware JE, Kosinski M, Tepper S, Dowson A, Bayliss MS, and
Batenhorst AS. Validation of the Headache Impact Test using patientreported symptoms and headache severity. In: Olesen J, Steiner TJ, and
Lipton RB, Eds. Reducing the Burden of Headache. Oxford: Oxford
University Press 2003. Chapter 13, pages 87-92.
Bayliss MS, Kosinski M, Diamond M, Tepper S, Garber WH, Ware JE,
and Batenhorst AS. HIT-6 scores discriminate among headache sufferers
differing in headache-associated workplace productivity loss. In: Olesen J,
Steiner TJ, and Lipton RB, Eds. Reducing the Burden of Headache.
Oxford: Oxford University Press 2003. Chapter 56, pages 338-342.
34
Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftell FD. Assessment
of Chronic Migraine Disability Using the Migraine Disability Assessment
(MIDAS) Questionnaire: A Comparison of Chronic Migraine with
Episodic Migraine. Headache 2003;43:336-342.
Rapoport AM, Bigal ME, Volcy M, Sheftell FD, Feleppa M, and Tepper
SJ. Naratriptan in the Preventive Treatment of Refractory Chronic
Migraine: A Review of 27 Cases. Headache 2003;43:482-489.
Bigal ME, Rapoport AM, Bordini CA, Tepper SJ, Sheftell FD, Speciali
JG. Burden of Migraine in Brazil: Estimate of Cost of Migraine to the
Public Health System and an Analytical Study of the Cost-Effectiveness of
a Stratified Model of Care. Headache 2003;43:742-754.
Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB, Weeks R,
Baskin SM. MMPI personality profiles in patients with primary chronic
daily headache. A case-control study. Neurol Sciences 2003;24:103-110.
Tepper SJ, Bigal ME, Rapoport AM, Sheftell FD. Botulinum toxin type A
in the preventive treatment of refractory headache: a review of 100
consecutive cases. Headache 2004;44:794-800.
Prince PB, Rapoport AM, Bigal AM, Sheftell FD, Tepper SJ. The Effect
of Weather on Headache. Headache 2004; 44:596-602.
Silberstein S, Tepper S, Brandes J, Diamond M, Goldstein J, Winner P,
Venkatraman S, Vrigjens F, Malbecq W, Visser WH, Reines S, and Yuen
E. Randomized, Double-Blind, Placebo-Controlled Trial of Rofecoxib for
the Acute Treatment of Migraine. Neurology 2004; 62: 1552-1557.
Dowson AJ, Tepper SJ, Vaos V, Baudet F, D’Amico D, and Kilminster S.
Identifying patients who require a change in their current acute migraine
treatment: the Migraine Assessment of Current Therapy (Migraine-ACT)
questionnaire. Current Medical Research and Opinion 2004;20:1125-35.
Sang CN, Ramadan RM, Wallihan RG, Chappell AS, Freitag FG, Smith TR,
Silberstein SD, Johnson KW, Phebus LS, Bleakman D, Ornstein PL, Arnold
B, Tepper SJ, and Vandenhende F. LY293558, a novel AMPA/GluR5
antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia
2004;24:596-602.
Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed
migraine and medication overuse in a tertiary headache center - clinical
characteristics and treatment outcomes. Cephalalgia. 2004;24(6):483-90.
35
Sheftell FD, Feleppa M, Tepper SJ, Volcy M, Rapoport AM, Bigal ME.
Patterns of use of triptans and reasons for switching them in a tertiary care
migraine population. Headache 2004;44:661-8.
Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB. Chronic daily
headache: Correlation between the 2004 and the 1988 International
Headache Society diagnostic criteria. Headache 2004;44:684-91.
Tepper SJ, Dahlof C, Dowson A, Newman L, Mansbach H, Jones M,
Pham B, Webster C, Salonen R. Prevalence and Diagnosis of Migraine in
Patients Consulting Their Primary Care Physician with a Complaint of
Headache: Data from The Landmark Study. Headache 2004;44:856-864.
Tepper SJ, D’Amico D, Baos V, Blakeborough P, Dowson AJ. Guidelines
for Prescribing Prophylactic Medications for Migraine: A Survey Among
Headache Specialists in Different Countries. Headache Care 2004;1:267272.
Sheftell FD, Feleppa M, Tepper SJ, Rapoport AM, Ciannella L, Bigal ME.
Assessment of Adverse Events Associated with Triptans- Methods of
Assessment Influence the Results. Headache 2004;44:978-993.
Bigal ME, Lipton RB, Tepper SJ, Rapoport AM, Sheftell FD. Primary
Chronic Daily Headache and its Subtypes in Adolescents and Adults.
Neurology 2004;63:843-847.
Rapoport AM, Bigal ME, Tepper SJ, Sheftell FD. Naratriptan in the
preventive treatment of refractory chronic migraine. In: Olesen J,
Silberstein SD, Tfelt-Hansen P., Eds. Preventive Pharmacotherapy of
Headache Disorders. Oxford: Oxford University Press 2004, pages 205211.
Tepper SJ, Baos V, Dowson AJ, Baudet F, D’Amico D, Kilminster S. The
Migraine Assessment of Current Therapy (Migraine-ACT) Questionnaire:
Further Investigation of Study Results. Headache Care 2005;2:27-31.
Dowson AJ, Tepper SJ, Baos V, Baudet F, D’Amico D, Kilminster S.
Identifying patients who require a change in their current acute migraine
treatment: the Migraine Assessment of Current Therapy (Migraine-ACT)
Questionnaire. Headache Care 2005;2:5-10.
Dowson AJ, Tepper SJ, Dahlof C. Patients’ preference for triptans and
other medications as a tool for assessing the efficacy of acute treatments
for migraine. J. Headache and Pain 2005; 6:112–20.
36
Bigal ME, Sheftell FD, Tepper SJ, Rapoport AM, Lipton RB. Migraine
days decline with duration of illness in adolescents with transformed
migraine. Cephalalgia. 2005;25:482-7.
Bigal ME, Rapoport AM, Tepper SJ, Sheftell FD, Lipton RB. The
classification of chronic daily headache in adolescents--a comparison
between the second edition of the international classification of headache
disorders and alternative diagnostic criteria. Headache. 2005;45:582-9.
Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Chronic
migraine is an earlier stage of transformed migraine in adults. Neurology.
2005;65:1556-61.
Sheftell FD, Rapoport AM, Tepper SJ, Bigal ME. Naratriptan in the
preventive treatment of refractory transformed migraine: a prospective
pilot study. Headache. 2005;45:1400-6.
Rapoport AM, Sheftell FD, Tepper SJ, Bigal ME. Levatiracetam in the
preventive treatment of transformed migraine: A prospective, open-label,
pilot study. Curr Ther Res Clin Exp. 2005:66:212-221.
Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C,
Kuhn TA. Oral sumatriptan for the acute treatment of probable migraine:
first randomized, controlled study. Headache. 2006 ;46:115-24.
Bigal ME, Gironda M, Tepper SJ, Feleppa M, Rapoport AM, Sheftell FD,
Lipton RB. Headache prevention outcome and body mass index.
Cephalalgia 2006;26:445–450.
Tepper SJ, Martin V, Burch SP, Fu AZ, Kwong J, Downs KE. Acute
Headache Treatments in Patients With Health Care Coverage: What
Prescriptions Are Doctors Writing? Headache and Pain 2006;17:11-17.
Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB. Field
Testing Alternative Criteria for Chronic Migraine. Cephalalgia
2006;26:477-482.
Kilminster SG, Dowson AJ, Tepper SJ, Baos V, Baudet F, D’Amico D.
Reliability, Validity, and Clinical Utility of the Migraine-ACT
Questionnaire. Headache 2006;46:553-562.
Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME.
Medications associated with probable medication overuse headache
reported in a tertiary care headache center over a 15-year period.
Headache. 2006 May;46(5):766-72.
37
Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. The
International Classification of Headache Disorders revised criteria for
chronic migraine- field testing in a headache specialty clinic. Cephalalgia
2007;27:230-234.
Bigal M, Rapoport A, Aurora S, Sheftell F, Tepper S, Dahlof C.
Satisfaction with Current Migraine Therapy: Experience from 3 Centers in
US and Sweden. Headache 2007;47:475-479.
Rapoport AM, Mathew NT, Silberstein SD, Dodick D, Tepper SJ, Sheftell
FD, Bigal ME. Zolmitriptan nasal spray in the acute treatment of cluster
headache: A double-blind study. Neurology 2007;69:821–826.
Bigal M, Sheftell F, Tepper S, Tepper D, Ho TW, Rapoport A. A
Randomized Double-Blind Study Comparing Rizatriptan, Dexamethasone,
and the Combination of Both in the Acute Treatment of Menstrually
Related Migraine. Headache 2008;48(9):1286-1293.
Bigal M, Rapoport A, Sheftell F, Tepper D, Tepper S. Memantine in the
Preventive Treatment of Refractory Migraine. Headache 2008;48
(9):1337-1342.
Tepper SJ, Zatochill M, Szeto M, Sheftell FD, Tepper DE, Bigal ME. A
Simple Menstrual Migraine OB/GYN Screener: The Menstrual Migraine
Assessment Tool (MMAT). Headache 2008;48:1419-1425.
Kung E, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. New daily
persistent headache in the paediatric population. Cephalalgia.
2009;29(1):17-22.
Kowacs PW, Piovesan EJ, Tepper SJ. Rejection and acceptance of
possible side-effects of migraine prophylactic drugs. Headache 2009;
49:1022-1027.
Tepper SJ, Rezai A, Narouze S, Steiner C, Mohajer P, Ansarinia M. Acute
Treatment of Intractable Migraine with Sphenopalatine Ganglion
Electrical Stimulation. Headache 2009; 49:983-989.
Ansarinia M, Rezai A, Tepper SJ, Steiner CP, Stump J, Stanton-Hicks M,
Machado A, Narouze, S. Electrical Stimulation of Sphenopalatine
Ganglion (SPG) for Acute Treatment of Cluster Headaches. Headache.
2010 Jul;50(7):1164-74.
Blumenfeld A, Ashkenazi A, Grosberg B, Napchan U, Narouze S, Nett B,
DePalma T, Rosenthal B, Tepper S, Lipton RB. Patterns of Use of
Peripheral Nerve Blocks and Trigger Point Injections among Headache
38
Practitioners in the US: Results of the American Headache Society
Interventional Procedure Survey (AHS-IPS). Headache 2010;50:937-942.
Whyte CA, Stillman MJ, Tepper SJ. Dihydroergotamine and its use in
migraine with posterior fossa symptoms. Headache 2010;50 (9): 14191423.
Cleves C, Rothner D, Parikh S, Tepper SJ. Link Between Confusional
Migraine, Hemiplegic Migraine and Episodic Ataxia Type 2: Hypothesis,
Family Genealogy, Gene typing and Classification. Cephalalgia 2010;30
(6):740-743.
Baron EP, Tepper SJ, Mays M, Cherian N. Acute Treatment of BasilarType Migraine with Greater Occipital Nerve Blockade. Headache
2010;50(6):1057-1059.
Aurora SK, Silberstein SD, Kori SH, Tepper SJ, Borland SW, Wang M,
Dodick DW. MAP0004, orally inhaled DHE: a randomized, controlled
study in the acute treatment of migraine. Headache. 2011 Apr;51(4):50717.
Tepper SJ, Kori SH, Goadsby PJ, Winner PK, Wang MH, Silberstein SD,
Cutrer M. MAP0004, Orally Inhaled DHE for the Acute Treatment of
Migraine: Efficacy of Early and Late Treatments. Mayo Clinic
Proceedings 2011; 86(10):948-955.
Baron EP, Cherian N, Tepper SJ. Role of Greater Occipital Nerve Blocks
and Trigger Point Injections for Patients with Dizziness and Headache.
The Neurologist 2011;17:312–317.
Tepper SJ, Kori SH, Borland SW, Wang MH, Hu B, Mathew NT,
Silberstein SD. Efficacy and Safety of MAP0004, Orally Inhaled DHE in
Treating Migraines With and Without Allodynia. Headache 2012;52(1):
37-47.
Tepper SJ, Lowe MJ, Beall E, Phillips MD, Liu K, Stillman MJ, Horvat
M, Jones SE. Iron Deposition in Pain-Regulatory Nuclei in Episodic
Migraine and Chronic Daily Headache by MRI. Headache 2012; 52(2):
236-243.
Baron EP, Moskowitz SI, Tepper SJ, Gupta R, Novak E, Hussain MS,
Stillman MJ. Headache Following Intracranial Neuroendovascular
Procedures. Headache 2012 May;52(5):739-48.
Landy SH, Tepper SJ, Wein T, Schweizer E, Ramos E. An Open-Label
Trial of a Sumatriptan Auto-Injector for Migraine in Patients Currently
Treated With Sumatriptan. Headache 2013;53(1):118-25.
39
Peterlin BL, Tietjen GE, Gower BA, Ward TN, Tepper SJ, White LW,
Dash PD, Hammond ER, Haythornthwaite JA. Ictal Adiponectin Levels in
Episodic Migraineurs: A Randomized Pilot Trial. Headache 2013;53:474490.
Almas M, Tepper SJ, Landy S, Schweizer E, Ramos E. Consistency of
eletriptan in treating migraine: Results of a randomized, within-patient
multiple-dose study. Cephalalgia. 2014;34(2):126-35.
Zheng Y, Tepper SJ, Covington EC, Mathews M, Scheman J.
Retrospective Outcome Analysis for Headaches in a Pain Rehabilitation
Interdisciplinary Program. Headache 2014;54(3):520-7.
Tepper SJ, Cady RK, Silberstein S, Messina J, Mahmoud RA, Djupesland
PG, Shin P, Siffert J. Breath Powered Nasal Delivery of Sumatriptan
Powder (AVP-825) vs Oral Sumatriptan in the Treatment of Acute
Migraine (the COMPASS Study): A Randomized Clinical Trial,
Headache 2015 May;55(5):621-635.
Vij B, Whipple MO, Tepper SJ, Mohabbat AB, Stillman M, Vincent A.
Frequency of Migraine Headaches in Patients with Fibromyalgia.
Headache 2015 June;55(6):860-865.
Case Reports, Technical Notes, Letters
Yung W, Tepper SJ, Young DF. Diffuse Bone Marrow Metastasis by
Glioblastoma: Postmortem Diagnosis by Peroxidase-antiperoxidase
Staining for Glial Fibrillary Acidic Protein. Ann Neurology. 1983: 14:581585.
Mullally WJ, Tepper SJ, Walshe TM 3rd, Wang AM, Samuels MA. A
misleading cervical bruit in carotid occlusion. N J Med. 1988
Jun;85(6):519-21.
Bertino RE, Porter BA, Stimac GK, Tepper SJ. Imaging Spinal
Osteomyelitis and Epidural Abscess with Short T1 Inversion Recovery
(STIR). Am J Neuroradiology. 1988; 9:563-564.
Millson D and Tepper S. Issues related to the assessment of migraine
recurrence following triptan therapy. Eur J. Neurology 1999;6(4):525-526.
Tepper SJ, Rapoport AM, Nett RB. Eletriptan’s clinical claims questioned.
Formulary 2000; 35:612-614 (Letter).
40
Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM. Hemicrania Continua: a
report of ten new cases. Arq Neuropsiquiatr 2002;60:695-698.
Rapoport AM, Bigal ME, Tepper SJ, Sheftell FD. Treatment of cluster
headache with topiramate: Effects and side-effects in five patients.
Cephalalgia 2003;23:69-70 (Letter).
Volcy M, Tepper SJ, Rapoport AM, Sheftell FD, Bigal MD. Short-lasting
unilateral neuralgiform headache attacks with cranial autonomic
symptoms (SUNA)—a case report. Cephalalgia 2005:25:470–472.
Volcy M, Sheftell FD, Tepper SJ, Rapoport AM, Bigal ME. Tinnitus in
migraine: an allodynic symptom secondary to abnormal cortical
functioning? Headache. 2005;45:1083-7.
Volcy M, Tepper SJ, Rapoport AM, Sheftell FD, Bigal MD. Botulinum
toxin A for the treatment of greater occipital neuralgia and trigeminal
neuralgia: a case report with pathophysiological considerations.
Cephalalgia,2006;26: 336–340.
Volcy M, Rapoport AM, Tepper SJ, Sheftell FD, Bigal ME. Persistent
idiopathic facial pain responsive to topiramate. Cephalalgia 2006:26:489491.
Bigal ME, Sheftell FD, Tepper SJ, Rapoport AM. Migraine and silent
infarcts. Are we making the proper decision? Cephalalgia 2006;26:629630.
Sun C, Lay C, Broner S, Silberstein S, Tepper S, Newman L. Reversible
Anorgasmia with Topiramate Therapy for Headache: A Report of 7
Patients. Headache 2006; 46:1450-1453.
Bigal ME, Sheftell FD, Tepper SJ, Rapoport AM. Discontinuation of
medication overuse in headache patients: recovery of therapeutic
responsiveness. Cephalalgia. 2007;27:568 (Letter).
Tepper SJ, Shapiro, RE, Sun-Edelstein C, Evans RW, Tietjen GE. Triptans
and Serotonin Syndrome- A Response. Headache 2012;52(7):1185-1188
(Letter).
41
Editorials, Reviews, Monographs, Journal Features, Chapters
Tepper SJ. Tardive Dyskinesia: An Iatrogenic Disorder. McGill Medical
Journal. 1979; 45:21-24.
Casey DE, Tepper SJ. Cholinergic Aspects of Tardive Dyskinesia. In:
Obiols J, Ballus C, Gonzalezmonclus E, Pujol J, eds. Biological
Psychiatry Today, Vol. 2. Amsterdam: Elsevier North Holland Biomedical
Press; 1979: 647
Tepper SJ, Haas, JF. Prevalence of Tardive Dyskinesia. J Clin Psychiatry.
1979; 39:508-516.
Tepper SJ. Neurologic Aspects of Sjogren's Syndrome. Moisture Seekers.
Nov 1993; 2:1-6.
Cady RK, Rosum RW, Solomon GD, Tepper SJ. Rational Therapy for
Headache. 1995; Institute for Contemporary Pharmacy Research (ICPRx).
Tepper SJ. A Primary Care Approach to Migraine and Chronic Headache.
Primary Care Reports 1996; 2:151-160.
Tepper SJ. From Moldy Bread to DHE: The Story of the Ergot Drugs.
American Council on Headache Education Newsletter. Spring 1997;8:1.
Tepper SJ. Book Review: Frontiers in Headache Research, Vol. 5.Olesen
J, Moskowitz M, eds. Neurology. 1997; 48:298.
Tepper SJ. Book Review: Office Practice of Neurology. Samuels MA, ed.
Neurology. 1997: 49:65A.
Tepper SJ. Migraine: Latest Options for Acute Therapy. Consultant. 1998;
38:1163-1175.
Tepper SJ. Recent Advances in Antimigraine Therapy: A Clinical
Overview of Zolmitriptan's Efficacy and Tolerability. Postgraduate
Medicine, Special Report. Jan 1998; 20-26.
Tepper SJ. Editorial: Sumatriptan Nasal Spray. Cephalalgia. 1998;18:242.
Gawel M, Tepper SJ. The Triptan Revolution. Seminars in Headache
Management. 1998; 3:1-10.
Tepper SJ. Selection of a New Triptan or Ergot For Your Patient.
Seminars in Headache Management.1998; 3:10-14.
42
Tepper SJ, Lucas SL. Highlights of the American Association for the
Study of Headache Meeting, San Francisco, California, June26-28, 1998.
Seminars in Headache Management.1998; 3:1-7.
Tepper SJ. Wolff Award Lecture by Richard Lipton, MD. Seminars in
Headache Management.1998; 3:7-8.
Lucas SL, Tepper SJ, Sheftell FD. Therapeutic Gain and the Triptans.
Seminars in Headache Management.1998; 3:13-14.
Tepper SJ, Rapoport AM. The Triptans: A Summary. CNS Drugs 1999(5);
12:403-417.
Tepper SJ. The Woman with Right Upper Facial Pain. In: Rapoport AM,
Purdy A, Sheftell FD, eds. Advanced Therapy of Headache, 1st Ed.
Hamilton, Ontario: B.C. Decker Inc Publisher 1999; Chapter 41, pages
271-276.
Sheftell, FD, Rapoport, AM, Purdy A, Tepper SJ. The Woman Who Could
Not Decide Which Medicine to Take. In: Rapoport, AM, Purdy A, Sheftell
FD, eds. Advanced Therapy of Headache. Hamilton, Ontario: B.C. Decker
Inc Publisher 1999; Chapter 5, 31-36. Reprinted in Neurology Reviews
2000; 8:12-16.
Tepper SJ. Triptan Update, Almotriptan, and Afterword. Also, editor for
Triptan Update section. American Council on Headache Education
Newsletter. Spring, 1999, Volume 10, Issue 1:1-6.
Tepper SJ. Rizatriptan- A New Agent for the Treatment of Migraine.
Today's Therapeutic Trends 1999;17:147-157.
Tepper SJ. Migraine update- the triptans: a clinical primer on their use.
Primary Care Reports 1999; 5:93-98.
Tepper SJ. Triptans: New drugs may provide relief to more migraineurs.
National Headache Foundation Headlines May/June 1999:2-4.
Tepper SJ. Advances in Headache Medicine: New Advances in Migraine
Preventive Medications. American Council on Headache Education
Newsletter. Fall, 1999, Volume 10, Issue 3: 9-11.
Tepper S. Use of Antidepressants in Headache Therapy. National
Headache Foundation Headlines March/April 2000:1-3.
43
Millson DS, Tepper SJ, Rapoport AM. Migraine pharmacotherapy with
oral triptans: a rational approach to clinical management. Expert Opin.
Pharmacotherapy 2000;1:391-404.
Tepper SJ. First-line treatment for migraine: analgesics or triptans;
Migraine-specific versus nonspecific treatment. American Council on
Headache Education Newsletter 2000;11(issue 2):1,6.
Tepper SJ, Sheftell FD, Rapoport AM. Evidence-Based Guidelines for
Migraine Headaches. Journal Watch Neurology 2000;2:70.
Tepper SJ, Rapoport AM. Book Review: Management of Headache and
Headache Medications, Second Edition. Robbins, L. Neurology
2000;55:1425.
Tepper SJ. Drug Interactions and the Triptans. CNS News 2001;3:27-29.
Tepper SJ. Safety and Rational Use of the Triptans. Medical Clinics of
North America July 2001;85:959-971.
Rapoport AM and Tepper SJ. Controversies in Neurology: Triptans are all
Different. Archives of Neurology 2001;58:1479-1480.
Tepper SJ and Gabb MG. Optimizing the Approach to Acute Treatment of
Migraine. Am J of Clinical Proceedings 2001;1:7-13.
Tepper SJ, Rapoport AM, Sheftell FD. The Pathophysiology of Migraine.
The Neurologist 2001;7:279-286.
Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ. Novas opções para o
tratamento preventivo da migrânea. Atualização com considerações
terapêuticas. Migrâneas e Cefaléias 2002;5:13-18.
Bigal ME, Rapoport AM, Sheftel FD, Tepper SJ. New Migraine
Preventive Options –An Update with Pathophysiological Considerations.
Rev Hosp Clin 2002;57:6:293-298.
Tepper SJ. Rapoport AM, Sheftell FD. Ethical Considerations in Cluster
Headache Research. Current Pain and Headache Reports 2002; 6:47-51.
Tepper SJ. Ask the Doctor column, American Council on Headache
Education Newsletter 2002;12(issue 4):6.
Tepper SJ. Headache Specialist Q&A: Using Antihypertensives in
Headache Therapy. NHF Headlines 2002; No. 125:6-7.
44
Sheftell, FD and Tepper SJ. New Paradigms in the Recognition and Acute
Treatment of Migraine. Headache 2002;42:58-69.
Tepper SJ. Book Review: The Triptans: Novel Drugs for Migraine, in
Humphrey P, Ferrari M, and Olesen J, Eds. The Lancet Neurology 2002;1:134.
Tepper SJ, Rapoport AM, Sheftell FD. Mechanisms of Action of the 5HT1B/1D Agonists. Archives of Neurology 2002;59:1084-1088.
Tepper SJ. Migraine: How to Use Acute Therapy Most Effectively.
Consultant 2002;42:977-981.
Tepper SJ and Dodick DW. Debate: Analgesic Overuse is a Cause, Not
Consequence, of Chronic Daily Headache. Headache 2002;42:543-554.
Tepper SJ. Triptans and the Potential for Drug Interactions (Revised
edition). CNS News 2002;4:25-28.
Tepper SJ. Predicting Effective Migraine Therapy: Response and
Recurrence. Headache Quarterly 2002;13:105-110.
Tepper SJ, Rapoport AM, Sheftell, FD. Abstract Review-Current Research
& Expert Commentary: Botulinum Toxin Type A for Headache, Migraine
and Beyond. NY: Rosemont Press, Inc, and Rogers Medical Intelligence
Solutions, 2003.
Bigal ME, Tepper SJ. Ergotamine and Dihydroergotamine: A Review.
Curr Pain Headache Reports 2003;7:55-62. and Curr Headache Reports
2003;2:11-18.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2003;43
(3): 299-308.
Tepper SJ, Rapoport AM, Sheftell FS. Strategies of Care for Acute
Treatment of Migraine. The Journal of Headache and Pain 2003;3:63-69.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2003;43
(4): 423-429.
Tepper SJ and Millson DS. Safety Profile of the Triptans. Expert Opinion
on Drug Safety 2003;2:123-132.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2003;43
(6): 686-692.
45
Rapoport AM, Tepper SJ, Bigal Marcelo E, Sheftell FD. The Triptan
Formulations: How to Match Patients and Products. CNS Drugs
2003;17:431-447.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2003;43
(7): 825-832.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2003;43
(8): 930-938.
Tepper SJ. Triptans and The Potential for Drug Interactions (3rd, Revised
Edition). CNS News 2003;5:39-42.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2003;43
(9): 1015-1023.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2003;43
(10): 1122-1128.
Dowson AJ, Sender J, Lipscombe S, Cady RK, Tepper SJ, Smith R, Smith
TR,Taylor FR, Boudreau GP, Van Duijn NP, Poole AC, Baos V, Woeber
C. Establishing principles for migraine management in primary care. Int J
Clin Pract 2003;57:493-507.
Tepper SJ and Rapoport AM. Coital Headache, in Aminoff M and Daroff
R, eds, Encyclopedia of the Neurological Science. San Diego: Academic
Press, 2003, pp. 510-511.
Tepper SJ. An overview of migraine pathophysiology, in Understanding
Migraine Headache: Recognition and Intervention, A Special Report.
Postgraduate Medicine Nov 2003.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2004;44
(1): 110-117.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2004;44
(2): 194-201.
Tepper SJ. New Thoughts on Sinus Headache. Allergy and Asthma Proc
2004; 25:1-2.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2004;44
(3): 295-302.
Rapoport AM, Bigal ME, Tepper SJ, and Sheftell FD. Zolmitriptan
(Zomig). Exp Review of Neurotherapeutics 2004;4:33-41.
46
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2004;44
(4): 377-383.
Sheftell FD, Bigal ME, Tepper SJ, Rapoport AM. Sumatriptan (Imitrex)-A
Decade of Use and Experience in the Treatment of Migraine. Exp Review
of Neurotherapeutics 2004;4:199-209.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2004;44
(5): 448-455.
Tepper SJ. Treatment of Headache Pain with Botulinum Neurotoxins.
Pain Practice 2004;4(Issue 1S):S38-S46.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2004;44
(6): 627-634.
Rapoport AM, Bigal ME, Tepper SJ, Sheftell FD. Intranasal medications
for the treatment of migraine and cluster headache. CNS Drugs,
2004;18:671-85.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2004;44
(7): 734-744.
Dowson AJ, Tepper SJ, Cady RK. New Initiatives for the Management of
Headache in Primary Care: Reviews of the Second Annual Meeting of the
Headache Care for Practising Clinicians (HCPC). Headache Care
2004;1:7-13.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2004;44
(8): 844-852.
Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. Chronic Daily
Headache- An Update. Headache Care 2004;1:222-245.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2004;44
(9): 936-943.
Tepper SJ. Drug Interactions in Headache: What to Watch for and Why.
ACHE Headache Newsletter 2004;15(3):7,11.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2004;44
(10): 1059-1068.
47
Tepper SJ and Reed L. What’s Hot in Headache Research: Potential
Therapies for Migraine, Cluster and Chronic Daily Headache. National
Headache Foundation NHF Headlines 2005;Jan/Feb 2005:1-4.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2005;45
(1): 91-98.
Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ. The Woman with
Never-Ending Headaches, in Purdy RA, Tepper SJ, Rapoport AM,
Sheftell FD, editors. Advanced Therapy of Headache, 2d Edition.
Hamilton, Ontario, London: BC Decker Inc, 2005, pages 109-112.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2005;45
(2): 179-187.
Tepper SJ. Herbs, Minerals, Vitamins, and Supplements in Migraine.
Primary Care Consultant 2005:45:662-666.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2005;45
(3): 260-267.
Tepper SJ. Alternative Medicine in Migraine: Is It Ever a Good
Alternative? Headache and Pain 2005;16:69-74.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2005;45
(4): 399-405.
Sheftell FD, Tepper SJ, Bigal ME. Migraine: barriers for care.
Neurol Sci. 2005;26 Suppl 2:s140-2.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2005;45
(7): 961-968.
Krymchantowski A and Tepper SJ. Nonspecific Migraine Acute
Treatment. In Lipton RB and Bigal ME, eds. Migraine and Other
Headache Disorders. NY: Informa Healthcare, 2005. Pp 273-288.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2005;45
(8): 1092-1100.
Rapoport AM, Tepper SJ, Sheftell FD, Kung E, Bigal ME. Which triptan
for which patient? Neurol Sci. 2006; 27 Suppl 2:s123-9.
Tepper SJ and Millson DS. Abstracts and Citations. Headache 2005;45
(9): 1271-1278.
48
Tepper SJ and Millson DS. Abstracts and Citations. Headache 2005;45
(10): 1421-1428.
Pereira Monteiro JMP, Tepper S, Shapiro RE. Headache Associated with
Acute Substance Use or Exposure, in Olesen J, Goadsby P, Ramadan N,
Tfelt-Hansen P, Welch MA, Editors, The Headaches, 3rd Ed.
Philadelphia: Lippincott Williams and Wilkins, 2006, Pp 959-969.
Vogler B, Rapoport AM, Tepper SJ, Sheftell F, Bigal ME. Role of
melatonin in the pathophysiology of migraine: implications for treatment.
CNS Drugs 2006;20:343-350.
Millson DS and Tepper SJ. Abstracts and Citations. Headache 2006;46
(1): 183-190.
Volcy Gomez M and Tepper SJ. Headaches. in Von Roenn JH, Paice JA,
Preodor ME, Editors. Current Diagnosis and Treatment of Pain. New
York: Lange Medical Books/McGraw-Hill, 2006, Pp 150-171.
Tepper SJ and Millson DS. Abstracts and Citations. Headache 2006;46
(2): 349-355.
Tepper SJ. Poor Response to One Triptan No Predictor of Response to
Others. Journal Watch Neurology 2006;8:49.
Tepper SJ. Abstracts and Citations. Headache 2006;46 (3): 535-543.
Tepper SJ. Tailoring Management Strategies for the Patient with
Menstrual Migraine: Focus on Prevention and Treatment. Headache
2006; 46 (CME Suppl 2):S61-S68.
Tepper SJ, Bigal ME, Dowson AJ. Abstracts and Citations. Headache
2006;46 (4): 695-702.
Tepper SJ. Acute Treatment of Migraine. Continuum Lifelong Learning
Neurol 2006(6);12:87-105.
Tepper SJ, Bigal ME, Dowson AJ. Abstracts and Citations. Headache
2006;46 (5): 821-827.
Diener H-C, Steiner TJ, Tepper SJ. Migraine- The Forgotten Epidemic:
Development of the EHF/WHA Rome Declaration on Migraine.
J Headache and Pain 2006;7:1-5.
Tepper SJ, Dowson AJ, Bigal M. Abstracts and Citations. Headache
2006;46 (6): 1024-1034.
49
Kaniecki R, Silberstein S, Tepper SJ. Emerging Concepts in Migraine
Therapy: Central Sensitization and Multiple Mechanisms of Migraine.
Neurology Reviews 2006;14 (CME Supplement, Dec 2006):1-15.
Tepper SJ and Bigal ME. Abstracts and Citations. Headache 2006;46 (7):
1213-1219.
Tepper SJ. Chronic Daily Headache, in Levin M and Ward TN, editors.
Head, Neck and Facial Pain: A Case-based Handbook of Diagnosis,
Management, and Prognosis. Columbus, Ohio: Anadem Publishing 2006.
Pp 25-29.
Tepper SJ and Bigal ME. Abstracts and Citations. Headache 2006;46 (8):
1311-1320.
Volcy M and Tepper SJ. Headaches. in Von Roenn JV, Preodor ME, Paice
JA, eds. Current Diagnosis and Treatment of Pain. NY: McGraw-Hill.
2006 Pp 150-171.
Taylor FR, Tepper SJ, Bigal ME. Abstracts and Citations. Headache
2006;46(9):1464-1473.
Tepper SJ, Bigal, M, Rapoport A, Sheftell F. Alternative Therapies:
Evidence Based Evaluation in Migraine. Headache Care 2006, 3:57-64.
Tepper SJ. Clinical Insights into Two Replicate Randomized DoubleBlind, Placebo-Controlled Trials of the Time to onset of Pain Relief in the
Acute Treatment of Migraine with a Fast-Disintegrating/Rapid-Release
Formulation of Sumatriptan Tablets. Clinical Impressions Dec 2006;1:2-4.
Tepper SJ, Bigal ME, Taylor FR. Abstracts and Citations. Headache
2007;47(1):140-150.
Tepper SJ, Bigal ME, Taylor FR. Abstracts and Citations. Headache
2007;47(2):303-311.
Tepper SJ. Trigger Points and Chronic Tension-type Headache. Journal
Watch Neurology 2007;9:5.
Tepper SJ, Bigal ME, Taylor FR. Abstracts and Citations. Headache
2007;47(3):454-460.
Tepper SJ. Treatment of menstrual migraine: evidence-based review.
Managed Care 2007;16 (Suppl 7):10-4.
50
Tepper SJ, Bigal ME, Taylor FR. Abstracts and Citations. Headache
2007;47(4):626-633.
Tepper SJ, Sheftell FD, Bigal ME. The Patent Foramen Ovale-Migraine
Question. Neurol Sci 2007;28:S118–S123.
Tepper SJ, Bigal ME, Taylor FR. Abstracts and Citations. Headache
2007;47(6):936-944.
Shapiro RE, Tepper SJ. The Serotonin Syndrome, Triptans, and the
Potential for Drug-Drug Interactions. Headache 2007;47:266-269.
Tepper SJ, Bigal ME, Taylor FR. Abstracts and Citations. Headache
2007;47(7):1103-1110.
Sheftell FD, Tepper SJ, Lay CL, Bigal M. Post-traumatic headache:
emphasis on chronic types following mild closed head injury. Neurol Sci
2007;28:S203-S207.
Tepper SJ, Stillman M, Taylor FR. Abstracts and Citations. Headache
2007;47(8):1234-1244.
Peterlin BL, Bigal ME, Tepper SJ, Urakaze M, Sheftell FD, Rapoport
AM. Migraine and adiponectin: is there a connection? Cephalalgia 2007;
27:435–446.
Taylor FR, Stillman M, Tepper SJ. Abstracts and Citations. Headache
2007;47(9):1354-1364.
Tepper SJ. Migraine Prevalence and Disease Burden. Journal Watch
Neurology 2007;9:50-51.
Tepper DE, Tepper SJ, Sheftell FD, Bigal ME. Headache Attributed to
Hypothryoidism. Current Pain and Headache Reports 2007;11:304-309.
Rawner E, Tepper SJ. 49th Annual Scientific Meeting of the American
Headache Society 2007: 6–10 June, 2007, Chicago, IL, USA. Expert Rev.
Neurotherapeutics 2007;7:1093–1095.
Tepper SJ. Acute Treatment of Menstrual Migraine. Current Pain and
Headache Reports 2007;6:169-173.
51
Newman LC, Cady RK, MacGregor EA, Shulman LP, Hutchinson SL,
Martin VT, Silberstein SD, Tepper SJ. A Multidisciplary Approach to
Treating Menstrual Migraine: An Algorithm for Short-term Prevention.
CME White Paper, University of Cincinnati and IMED Communications.
Califon, NY: IMED Communications, November 2007.
Stillman MJ, Tepper SJ, Taylor FR. Abstracts and Citations. Headache
2008;48(1):169-179.
Tepper SJ and Stillman MJ. Is It Sinus Headache or Migraine? Journal
Watch Neurology 2008; 10:36-37.
Tepper SJ, Stillman MJ, Taylor FR. Abstracts and Citations. Headache
2008;48(2):301-310.
Tepper SJ. A Pivotal Moment in 50 years of Headache History: The First
American Migraine Study. Headache 2008; 48:730-1.
Taylor FR, Tepper SJ, Stillman MJ. Abstracts and Citations. Headache
2008;48(3):482-490.
Tepper SJ and Koch TK. Complementary and Alternative Treatments for
Childhood Headaches, in Winner P, ed. Headache in Children and
Adolescents, 2d Ed. Hamilton, Ontario: BC Decker, 2008, pages 283-295.
Stillman MJ, Taylor FR, Tepper SJ. Abstracts and Citations. Headache
2008;48(4):646-658.
Tepper SJ. Evidence-based Basics on Nutraceuticals: Herbs, Minerals,
Vitamins, and Supplements in Migraine Management. Information for
Health Care Professionals, American Headache Society 2008.
Tepper SJ, Stillman MJ, Taylor FR. Abstracts and Citations. Headache
2008;48(6):976-988.
Tepper SJ. Preventive Pharmacologic Treatment of Migraine and Tensiontype Headache, in Levin M, ed. The Headache Cooperative of New
England Comprehensive Review of Headache Medicine. Oxford: Oxford
University Press, 2008, pages 231-254.
Taylor FR, Stillman MJ, Tepper SJ. Abstracts and Citations. Headache
2008;48(7):1140-1145.
Sun-Edelstein C, Tepper SJ, Shapiro RE. Drug-Induced Serotonin
Syndrome: A Review. Expert Opin. Drug Safety 2008: 7(5):1-10.
52
Taylor FR, Tepper SJ, Stillman MJ. Recent Studies on PFO and Migraine:
Is There a Future for Closure? Headache 2008;48(7):1083-1086.
Tepper SJ. PFO and Migraine: Association and Causation.
Cleveland Clinic Neuroscience Pathways Fall/Winter 2008;16-17.
Cleves C, Tepper SJ. Sumatriptan Naproxen Sodium Combination for the
Acute Treatment of Migraine. Expert Review of Neurotherapeutics 2008;
8(9), 1289–1297.
Stillman MJ, Tepper SJ, Taylor FR. Abstracts and Citations. Headache
2008;48:1243-1253.
Tepper SJ and Stillman MJ. Clinical and Preclinical Rationale for CGRP
Antagonists in the Treatment of Migraine. Headache (Headache Currents)
2008;48:1259-1268.
Tepper SJ, Taylor FR, Stillman MJ. Abstracts and Citations. Headache
2008;48(9):1385-1395.
Tepper SJ. Complementary and Alternative Treatments for Childhood
Headaches. Current Pain and Headache Reports 2008, 12:379–383.
Wenzel RG, Tepper S, Korab WE, Freitag F. Serotonin syndrome risks
when combining SSRI/SNRI drugs and triptans: literature review and
recommendations. Annals of Pharmacotherapy 2008;42(11):1692-6.
Tepper SJ and Mays M. Up-to-date pharmacologic options for managing
headache pain. Medscape Neurology and Neurosurgery 2008; posted Oct
30, 2008.
Dowson AJ and Tepper SJ. Editorial : Migraine: improved outcomes in
patients previously poorly responsive to therapy. Int J Clinic Practice
2008;62(12):1822-1824.
Kriegler J and Tepper SJ. Facial Pain and Trigeminal Trophic Syndrome.
Journal Watch Neurology 2008;10:92-93.
Tepper SJ. Perimenstrual Migraines: Are They Different Than Migraines
in General? Current Pain and Headache Reports 2008; 12 (6):463-7.
D’Amico D and Tepper SJ. Prophylaxis of Migraine: General Principles
and Patient Acceptance. Neuropsychiatric Disease and Treatment
2008:4(6) 1–13.
53
Tepper SJ and Spears RC. Acute Treatment of Migraine. In Evans, R. Ed.
Migraine and other Primary Headaches, Neurologic Clinics 2009; 27
(2):417-427. NY: Elsevier.
Tepper SJ, Cleves C, Taylor FR. Patent Foramen Ovale and Migraine:
Association, Causation, and Implications of Clinical Trials. Current Pain
and Headache Reports 2009;13:221–226.
Tepper SJ. Commentary: How different is migraine prevalence among the
races? Headache 2009;49: 894.
D’Amico D and Tepper SJ. Key Points in Migraine Prophylaxis: Patient
Perspective. Neurol Sci 2009; 30 (Suppl 1):S39–S42.
Tepper SJ and Cleves C. Telcagepant, a calcitonin gene-related peptide
antagonist for the treatment of migraine. Current Opinion in
Investigational Drugs 2009; 10(7):711-720.
Bamford CC and Tepper SJ. Daily Pharmacologic Prophylaxis of Episodic
Migraine. Techniques in Regional Anesthesia and Pain Management
2009;13(1): 20-37.
Tepper SJ and Kriegler JS. Update on Menstrual Migraine, The Female
Patient, July 2009 ;34 (7):17-24.
Whyte C and Tepper SJ. Adverse Effects of Medications Commonly Used
in the Treatment of Migraine. Expert Review of Neurotherapeutics
2009;9(9):1379-1391.
Hutchinson SL and Tepper SJ. Treatment and management of migraineThe Road Ahead. US Neurology, 2009;5(1):72-74.
Tepper SJ. What is CGRP and What Should You Know About It?
Answers to Why Everyone is Talking About CGRP Receptor Antagonists.
American Headache Society American Council on Headache Education
(ACHE) Newsletter 2009;1(3):8-9.
Tepper SJ and Tepper DE. How Do I Do It- Acute Treatment of Migraine.
American Headache Society CME, at
www.AmericanHeadacheSociety.org, 2009, Pp 1-9.
Katic´ BJ, Krause SJ, Tepper SJ, Hu HX, Bigal ME. Adherence to Acute
Migraine Medication: What Does It Mean, Why Does It Matter?
Headache 2010;50(1):117-132.
Whyte C, Tepper SJ, Evans R. Rescue Me: Rescue Medication for
Migraine, Headache 2010;50(2):307-313.
54
Whyte C and Tepper SJ. Pearls and “Oy-sters”: Trigeminal Autonomic
Cephalalgias, Neurology. 2010;74(11):e40-2.
Tepper SJ and Tepper DE. Medication Overuse Headache: Breaking the
Cycle. Cleveland Clinic Journal of Medicine 2010; 77(4):236-242.
Tepper SJ, Gonzalez J, Levin M. Resident and Fellow Section Teaching
Case: Migraine Stroke. Headache 2010;50(4):687-691.
Baron EP and Tepper SJ. Biofeedback for Migraine and Tension-Type
Headache. Journal Watch Neurology 2010;12(5):39.
Baron EP, Tepper SJ. Revisiting the Role of Ergots in the Treatment of
Migraine and Headache. Headache 2010;50: 1353-1361.
Ashkenazi A, Blumenfeld A, Napchan U, Narouze S, Nett B, DePalma T,
Rosenthal B, Tepper SJ, Lipton RB. Peripheral Nerve blocks and Trigger
Point Injections in Headache Management - A Systematic Review and
Suggestions for Future Research, Headache 2010;50(6):943-952.
Evans RW, Tepper SJ, Shapiro RE, Sun-Edelstein C, Tietjen GE. The
FDA alert on Serotonin Syndrome with Use of Triptans Combined with
Selective Serotonin Reuptake Inhibitors or Selective SerotoninNorepinephrine Reuptake Inhibitors: American Headache Society Position
Paper. Headache 2010;50(6):1089-1099.
Tepper SJ and Tepper DE. Medication Overuse Headache, in Refractory
Headache and Its Treatment. In Refractory Migraine, Schulman EA,
Levin M, Lake AE and Loder E, eds, NY: Oxford University Press, 2010,
Pp 136-159.
Tepper SJ. The Role of Prevention. In Handbook of Clinical Neurology,
3rd Series. In Aminoff M, Nappi G and Moskowitz M, eds. NY: Elsevier,
2010, pages 195-205.
Kelley NE and Tepper SJ. Defining New Daily-Persistent Headache.
Journal Watch Neurology 2010 Nov;12 (11):85.
Bamford CC, Mays M, Tepper SJ. Unusual Headaches in the Elderly.
Curr Pain Headache Rep. 2011; 15(4):295-301.
Baron EP and Tepper SJ. Orally inhaled dihydroergotamine: reviving and
improving a classic. Future Neurology. 2011;6(3):327-333.
55
Jenkins B and Tepper SJ. Neurostimulation for primary headache
disorders, part 1: pathophysiology and anatomy, history of
neuromodulation inheadache treatment, and review of peripheral
neuromodulation in primary headaches. Headache 2011;51(8):1254-66.
Jenkins B and Tepper SJ. Neurostimulation for Primary Headache
Disorders: Part 2, Review of Central Neurostimulators for Primary
Headache, Overall Therapeutic Efficacy, Safety, Cost, Patient Selection,
and Future Research in Headache Neuromodulation.
Headache. 2011;51(9):1408-18.
Tepper SJ. Editorial: Serotonin Syndrome: SSRIs, SNRIs, Triptans, and
Current Clinical Practice. Headache 2012;52(2): 195-197.
Tepper SJ and Stillman MJ. What is the best drug-delivery approach for
the acute treatment of migraine? Expert Review of Neurotherapeutics 2012
Mar;12(3):253-5.
Tepper SJ. Opioids Should Not Be Used in Migraine. Headache 2012;
52(S1):50-54.
Tepper SJ and Rothrock JF. Conclusions on Opioids. Headache 2012;
52(S1):39-39.
Tepper SJ. Advanced Interventions for Headache. Headache 2012;
52(S1):30-34.
Da Silva AN, Tepper SJ, and Evans RW. Expert Opinion in Headache:
Side-Locked and Side Shifting Primary Headaches. Headache 2012;52(7):
1178-1183.
Tepper SJ. Medication Overuse Headache. Continuum Lifelong Learning
Neurol 2012;18(4):807–822.
Da Silva AN and Tepper SJ. Acute Treatment of Migraine. CNS Drugs
2012, CNS Drugs. 2012 Oct 1;26(10):823-39.
Stillman MJ, Tepper SJ, Tepper DE, Cho L. QT Prolongation, Torsade de
Pointes, Myocardial Ischemia From Coronary Vasospasm, and Headache
Medications. Part 1: Review of Serotonergic Cardiac Adverse Events With
a Triptan Case. Headache 2013: 2013;53(1):208-216.
56
Stillman MJ, Tepper DE, Tepper SJ, Cho L. QT Prolongation, Torsade de
Pointes, Myocardial Ischemia From Coronary Vasospasm, and Headache
Medications. Part 2: Review of Headache Medications, Drug–Drug
Interactions, QTc Prolongation, and Other Arrhythmias. Headache
2013;53(1):217-24.
Tepper SJ. Editorial. Headache 2013;53(1):207.
Lakhan SE, Avramut M, Tepper SJ. Structural and Functional
Neuroimaging in Migraine: Insights from Three Decades of Research.
Headache 2013;53(1):46-66.
Estemalik E, Tepper SJ. Preventive Treatment in Migraine and the New
US Guidelines. Neuropsychiatric Disease and Treatment 2013;9:709-20.
Tepper SJ. Migraine Pathophysiology. Headache Currents Commentary
Online Feb 2013;
http://www.headachejournal.org/view/0/HCFeb2013.html.
Tepper SJ and Stillman MJ. Cluster Headache: Potential Options for
Medically Refractory Patients (When All Else Fails). Headache Currents
2013;53(7):1183-1190.
Tepper SJ. Orally Inhaled Dihydroergotamine: A Review. Headache
2013;53 (Supplement 2):43-53.
Tepper SJ, Chen S, Reidenbach F, Rapoport AM. Intranasal zolmitriptan
for the treatment of acute migraine. Headache 2013;53 (Supplement 2):
62-71.
Tepper SJ. Clinical Implications for Breath-Powered Powder Sumatriptan
Intranasal Treatment. Headache 2013;53(8):1341-1349.
Tepper SJ. International Classification of Headache Disorders, 3rd
Edition, beta version. Headache Currents 2013; 53(8):1381-1382.
Tepper SJ. Traumatic Brain Injury (TBI), Pain, and Headache. Headache
Currents 2013; 53(9):1517.
Lakhan SE, Tepper SJ, Avramut M. Sphenopalatine Ganglion Stimulation
in Primary Headaches. Future Medicine: Novel Approaches in Migraine
Treatment Aug 2013:120-132, DOI: 10.1177/0333102412473667.
Tepper SJ. Medication Overuse Headache. Headache Currents
2014;54(1):203.
57
Tepper SJ. Idiopathic Intracranial Hypertension and Low CSF Pressure
Headaches. Headache Currents 2014;54(2):387-388.
Tepper SJ. Vasculitis, Endothelial Disorder, and Headache.
Currents 2014;54(3):571.
Headache
Tepper SJ. Complementary and Alternative Medicine (CAM), Ayurvedic
Medicine, and Research into Behavioral and Mind/Body Interventions in
Headache. Headache Currents 2014;54(6):1114.
Tepper SJ. Chronic Migraine and Medication Overuse Headache.
Headache Currents 2014;54(7):1249-50.
Messali AJ, Yang M, Gillard JP, Tsai K, Tepper SJ, Bloudek LM, Kori
SH. Treatment Persistence and Switching in Triptan Users: A Systematic
Literature Review. Headache 2014;54(7):1120-30.
Mays M and Tepper SJ. Occipital Nerve Blocks, in Narouze SN. Editor,
Interventional Management of Head and Face Pain. NY: Springer, 2014,
P. 29-34.
Tepper SJ. Nutraceutical and Other Modalities for the Treatment of
Headache. Neurology Continuum (Minneap Minn) 2015;21(4):1018–1031.
Books
Rapoport AM, Sheftell FD, Tepper SJ. Conquering Headache, 3rd Edition.
Hamilton, Ontario: B.C. Decker Inc Publisher, 2001.
Tepper SJ, Rapoport AM, Sheftell FD, eds. The Spectrum of Migraine,
NYC: McMahon Publishing, 2002.
Rapoport AM, Sheftell FD, Tepper SJ. Conquering Headache, 4th Edition.
Hamilton, Ontario: B.C. Decker Inc Publisher, 2003.
Tepper SJ. Understanding Migraine and Other Headaches. Jackson, Miss:
University of Mississippi Press, 2004.
Rapoport AM, Sheftell FD, Tepper SJ. Conquering Headache, 5th Edition.
Hamilton, Ontario, London: Decker DTC, 2004.
Purdy RA, Tepper SJ, Rapoport AM, Sheftell FD, editors. Advanced
Therapy of Headache, 2d Edition. Hamilton, Ontario, London: BC Decker
Inc, 2005.
58
Rapoport AM, Sheftell FD, Blumenfeld A, and Tepper SJ. Conquering
Daily Headache. Hamilton, Ontario: B.C. Decker Inc Publisher, 2008.
Tepper SJ and Tepper DE, editors. Cleveland Clinic Manual of Headache
Therapy. NY: Springer Publishing, 2011.
Tepper SJ and Tepper DE, editors. Cleveland Clinic Manual of Headache
Therapy, Second Edition. NY: Springer Publishing, 2014.
In press or submitted
Maasumi K, Thompson NR, Kriegler JS, Tepper SJ. Effect of OnabotulinumtoxinA
Injection on Depression in Chronic Migraine, Headache in press, 2015.
Abstracts
Drucker P, Tepper SJ. Repetitive Outpatient Oral Sumatriptan in Detoxification for
Patients with Transformed Migraine with Medication Overuse. Headache. 1997; 37:307308.
Winner P, Sheftell F, Ryan R, Tepper SJ. Overview of the Clinical Response to
Zolmitriptan in Migraineurs Identified as 'Poor Responders' to Other Migraine
Preparations. Headache. 1997:37:336-337.
Tepper SJ, Millson DS. Zolmitriptan ('Zomig', 311C90) is Efficacious in Migraine on
Awakening. J Neuological Sciences. 1997;150:S106.
Solomon GD, Sheftell FD, Tepper SJ. Clinical effectiveness of 'Zomig' (Zolmitriptan,
311C90) in established migraine (>=4hours pretreatment duration). J Am Osteopathic
Ass. 1997;97:489.
Tepper S, Ward T, Maurer C. Patient-reported Tablet Utilization of Zolmitriptan and
Sumatriptan. Headache. 1998; 38: 408-409.
Tepper SJ, Millson D. The new triptans (5-HT 1B/1D agonists for acute treatment of
migraine: a clinical review using number needed to treat (NNT) analysis. European
Journal of Neurology 1998; 5 (Suppl 3):S55.
59
Saper J, Podolnick P, Klapper J, Tepper S, Stacey B, Rapoport A, Ramadan N. Efficacy
and safety of gabapentin (Neurontin) in Migraine Prophylaxis. Cephalalgia 1999; 19:380.
Millson D and Tepper S. Issues relating to the assessment of migraine recurrence
following triptan therapy. European Journal of Neurology 1999; 6:1-2.
Tepper SJ, Allen CP, Vandormael K. therapeutic benefit of rizatriptan compared with
eletriptan. Cephalalgia 2000;20:355, and Eur J Neurology 2000 7(Suppl 3):86.
Sheftell FD, Weeks RE, Tepper SJ, Fox AW. Number Needed to Treat Depends on
Placebo Response Rate. Cephalalgia 2000;20:323.
Ware, JE, Kosinski M Diamond M, Bayliss MB, Tepper S, Dowson A, Batenhorst AS.
Validation of the headache impact test using patient-reported symptoms and headache
pain severity. Cephalalgia 2000;20:320.
Tepper SJ, Meddis D. Reducing the cost of impairment of Normal Activities due to
Migraine: A Stratified-Care Approach. Headache 2000; 40:434-435.
Bayliss MS, M Kosinski M, Diamond M, Tepper S , Garber WH, Ware J, Batenhorst A.
HIT-6 Scores Discriminate Among Headache Sufferers Differing in HeadacheAssociated Workplace Productivity Loss. Neurology 2001;56 (Suppl 3):A139.
Sang CM, Ramadan NM, Chappell AS, Freitag FG, Smith TR, Silberstein SD, Tepper SJ.
A double-blind, placebo-controlled study to investigate the efficacy and tolerability of
intravenous 1.2 mg/kg LY293558 vs. 6 mg subcutaneous sumatriptan vs. placebo in
patients with an acute migraine attack. Neurology 2001;56 (Suppl 3):A219. [Winner of
the Best of the Best award].
Tepper SJ. Acute Treatment of Migraine: Issues of Disability and Early Intervention.
Proceedings of the 15th Italian Society for the Study of Headache. Florence, Italy, June
10-13, 2001, P.60.
Gallai B, Tepper SJ, Rapoport AM. Cefalia Cronica Quotidiana in Eta’Evolutiva: Studio
Retrospettivo Presso Il New England Center for Headache (Connecticut, USA).
[Adolescent Chronic Daily Headhache, a Retrospective Study from The New England
Center for Headache]. Proceedings of the 15th Italian Society for the Study of Headache.
July 10-13, 2001, P.53.
Kosinski M, Garber WH, Diamond M, Tepper S, Bayliss MS, Bjorner JB, Batenhorst A.
HIT-6 Scores Discriminate Among Headache Sufferers. J Neurological Sciences
2001;187(Suppl 1):S13.
60
Garber WH. Kosinski M, Dahlof C, Tepper S, Kujawski SC, Bjorner JB, Batenhorst A.
HIT-6 Reliably Measures the Impact of Headache. J Neurological Sciences
2001;187(Suppl 1):S122., also in Cephalalgia 2001;21:333.
Ramadan N, Sang C, Chappell A, Vandenhende F, Johnson K, Phebus L, Bleakman D,
Ornstein P, Arnold B, Freitag F, Smotih T, Silberstein S, Tepper S. IV LY293558, an
AMPA/KA antagonist, is effective in migraine. Cephalalgia 2001;21:267.
Tepper S, Dahlof C, Sheftell F, Dewey J, Batenhorst A. Impact of migraine relative to
other headache types. Cephalalgia 2001;21:331-332.
Bayliss MS, Kosinski M, Diamond M, Tepper S, Garber WH, Ware J, Batenhorst A.
HIT-6 scores discriminate among headache sufferers differing in headache-associated
workplace productivity loss. Cephalalgia 2001;21:333-334.
Dahlof C, Tepper S, Pryse-Phillips W, Dewey J, Batenhorst AS, Davis K, Barhout VE.
Comparability of scores on the Headache Impact Test (HIT) and HIT-6. Cephalalgia
2001;21:334-335.
Tepper SJ. Almotriptan demonstrated a consistent response across multiple migraine
attacks during a 1-year trial. Cephalalgia 2001;21:430.
Sheftell FD, Tepper SJ. Hypothesis:trigeminal myofascial system (TGM): hypothesis for
the relationship between tension-type headache and migraine. Cephalalgia 2001;21:471.
Bigal ME, Rapoport AM, Sheftell, FD, Lipton RB, Tepper SJ. Headache Associated with
Medication Overuse: Data from Tertiary Care. Neurology 2002 (Suppl 3);58: A170-171.
Bigal ME, Sheftell, FD, Rapoport AM, Lipton RB, Tepper SJ. Evaluation of Chronic
Daily Headache: Correlation between the International Headache Society and the
Proposed Headache Classification for Chronic Daily Headache Systems. Neurology 2002
(Suppl 3);58: A172.
Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB. Chronic Daily Headache:
Identification of Factors Associated with Induction and Transformation. Headache
2002;42:428.
Bigal ME, Rapoport AM, Lipton RB, Tepper SJ, Sheftell FD. Burden of Migraine in
Brazil I: An Estimate of the costs of Migraine to the Public Health System.
Headache 2002;42:419-420.
Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM, Lipton RB. Burden of Migraine in
Brazil 2: An Analytical Study of the Cost Effectiveness of a Stratified Model of Care.
Headache 2002;42:426-427.
61
Moore WMM, Kwong WJ, Tepper SJ, Bowers BW, Batenhorst AS Bayliss MS.
Sensitivity of Headache Impact Test (HIT) in Distinguishing Headache Impact among
Headache Sufferers Receiving Pharmacologic Treatment. Neurology 2002 (Suppl 3);58:
A416-417, also in Headache 2002; 42:423-424, also in Cephalalgia 2002 (suppl 1):2526.
Tepper S, Ryan R, Rapoport A, Abu-Shakra S. Efficacy of Oral Zolmitriptan 2.5 mg in
Mild, Moderate and Severe Migraine: Results of Treating More than 20,000 Attacks.
Neurology 2002 (Suppl 3);58: A417.
Tepper S, Allen C, Sanders D, Greene A, Boccuzzi S. Co-prescription of triptans with
potentially interacting medications: a cohort study involving 240,268 patients. Headache
2002;42:397; also in European Journal of Neurology 2002;9(Supp l2):150.
Tepper S, Allen C, Sanders D, Greene A, Boccuzzi S. Co-prescription of triptans with
other medications. Cephalalgia 2002;22 (suppl1):6-7.
Loder E, Silberstein SD, Smith T, Tepper S, Mueller L, Abu-Shakra S. Oral Zolmitriptan
Shows Efficacy as Early as 30 Minutes in the Treatment of Migraine Associated with
Menses: Results of a Large Multicenter Placebo-controlled Study. Headache
2002;42:397.
Rapoport AM, Bigal M, Lipton RB, Sheftell FD, Tepper SJ. Assessment of Chronic
Migraine Disability Using the Migraine Disability Assessment Scale (MIDAS): A
Comparison with Episodic Migraine. Headache 2002;42:432.
Sheftell FD, Bigal M, Tepper SJ, Rapoport AM, Lipton RB. Clinical Presentation of
Chronic Daily Headache Possible Differences Among Its Subtypes. Headache
2002;42:434.
Moore WMM, Kwong WJ, Tepper SJ, Diamond ML, Bayliss MS, Batenhorst AS. Profile
of Adolescents Headache Sufferers completing the Headache Impact Test via the
Internet. Headache 2002; 42:442-443.
Bayliss M, Dewey J, Tepper S, Cady R, Diamond M, Batenhorst A, Kwong J. Value of
delivering health status assessment via the internet. Cephalalgia 2002;22 (suppl 1):10-11.
Dowson A, Dahlof C, Tepper S, Newman L. Prevalence and Diagnosis of Migraine in a
Primary Care Setting. Cephalalgia 2002;22:590-591.
Dowson A, Dahlof C, Tepper S, Newman L. The Spectrum of Headaches Experienced by
Migraineurs in a Primary Care Setting. Cephalalgia 2002;22:591.
Tepper SJ, Dowson A, Newman L, Dahlof C, Webster C, Petrie J, Pham B. Landmark
Study Group. Expert Panel Review of Patient Diary Data Using IHS Classification.
Cephalalgia 2002;22: 611.
62
Tepper S, Dowson A, Dahlof C, Newman L, Kinrade F, Loftus JV. Prevalence and
Diagnosis of Migraine in a Primary Care Setting. European Journal of Neurology
2002;9(Supp l2):43.
Dahlof C, Tepper S, Dowson A, Newman L, Pham B, Kwong J, Jones M. Reduced
headache impact after three months of sumatriptan migraine therapy in the primary care
setting. European Journal of Neurology 2002;9(Supp l2):44.
Newman L, Tepper S, Dahlof C, Dowson a, Malik F, Loftus JV. The Spectrum of
Headaches Experienced by Migraineurs in a Primary Care Setting. European Journal of
Neurology 2002;9(Supp l2):186-187.
Tepper S, Dahlof C, Newman L, Dowsonon A, Pham B, Kwong J, Scott A. Association
of headache impact test (HIT-6) and IHS migraine diagnosis in the primary care setting.
European Journal of Neurology 2002;9(Supp l2):187.
Silberstein S, Tepper S, Brandes J, Diamond M, Goldstein J, Winner P, Venkatraman S,
Vrigjens F, Malbecq W, Visser WH, Reines S, and Yuen E. A Randomized, DoubleBlind, Placebo-Controlled Trial of Rofecoxib for the Acute Treatment of Migraine.
Neurology 2003;60 (Supp 1):A337.
Sheftell FD, Bigal ME, Rapoport AM, Feleppa M, Tepper SJ. Determinants of Triptan
Preference in a Tertiary Care Migraine Population: Patterns of Use. Neurology 2003;60
(Supp 1):A237; also in Cephalalgia 2003;23:714.
Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM. Botulinum Toxin A in the Preventive
Treatment of Refractory Headache. Neurology 2003;60 (Supp 1):A323. Also in the 2003
APS Database.
Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Feleppa M. Triptan Use in a
Migrainuer Population. Determinants of Preference. Neurology 2003;60 (Supp 1):A170171.
Rapoport AM, Bigal ME, Volcy M, Shertell FD, Feleppa M, Tepper SJ. Naratriptan in
the Preventive Treatment of Refractory Chronic Migraine. Neurology 2003;60 (Supp
1):A254.
Prince PB, Rapoport AM, Bigal AM, Sheftell FD, Tepper SJ. The Effect of Weather on
Headache. Neurology 2003;60 (Supp 1):A513. Also Headache 2004;44:513.
Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, and Lipton RB. Correlation Between
the 1988 International Headache Society diagnostic Criteria, the 2003 Revised Criteria,
and the Proposed Revisions of Criteria for Chronic Daily Headache. Headache
2003;43:509-510.
63
Silberstein S, Tepper S, Brandes J, Diamond M, Goldstein J, Winner P, Venkatraman S,
Vrigjens F, Malbecq W, Visser WH, Reines S, and Yuen E. Efficacy and Safety of
Rofecoxib for the Acute Treatment of Migraine: Results of a Randomized, Placebocontrolled Trial. Headache 2003;43:524.
Sheftell FD, Bigal ME, Tepper SJ, and Rapoport AM. Patterns of Use of Triptans in a
Tertiary Care Migraine Population. Headache 2003;43:534-535.
Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM. The Effect of Botulinum toxin on the
Disability of Refractory Headaches. Headache 2003;43:578-579.
Tepper S, and Freitag F. Prophylactic Use of Frovatriptan for Menstrually Associated
Migraine is Effective and Does Not Cause Rebound Migraine in the Postdosing Period.
Headache 2003;43:585.
Rapoport AM, Bigal ME, Tepper SJ, and Sheftell FD. Naratriptan in the Preventive
Treatment of Refractory Chronic Migraine. Headache 2003;43:578-579.
Dahlof C, Dowson A, Newman L, Tepper S, Pham B. Headache Spectrum: Insight from
the Landmark Study, Cephalalgia 2003:23:622.
Tepper S, Dahlof C, Dowson A, Newman L, and Kuhn TA. Prevalence and
demographics of migrainous headache adults in a primary care setting: data from the
Landmark Study. Cephalalgia 2003:23:622.
Sheftell F, Bigal M, Volcy M, Tepper S, Weeks R. Tolerability and efficacy are related
after triptan use. Cephalalgia 2003;23:697.
Bigal M, Tepper S, Rapoport A, Feleppa M, Sheftell F. ‘Switching’ behaviors in
longitudinal use of triptans. Cephalalgia 2003;23:705.
Rapoport A, Bigal M, Sheftell F, Volcy M, Feleppa M, Tepper S. Naratriptan in the
preventive treatment of refractory chronic migraine. Cephalalgia 2003;23:751.
Tepper S, Bigal M, Sheftell F, Rapoport A. Botulinum Toxin type A in the preventive
treatment of refractory headaches- comparison between medication overusers and
nonmedication overusers groups. Cephalalgia 2003;23:715.
Sheftell FD, Feleppa M, Tepper SJ, Rapoport SJ, Rapoport AM, Bigal ME. Adverse
Events Associated with Triptans- Methods of Assessment Influence the Results.
Headache 2004;44:470.
Tepper S, Dodick D, Cady R, Lucas S, Hutchinson S, Few C, Kuhn T. Oral Sumatriptan
for Probable Migraine Without Aura (2004 IHS 1.6.1): Results of a Randomized,
Double-Blind Placebo-Controlled Study. Headache 2004;44:477-478.
64
Lipton R, Dodick D, Cady R, Tepper S, Few C, Kuhn T. Headache Response Sustained
Through 4 Hours in Adults with Probable Migraine in a Controlled Clinical Study.
Should Response Rates Include Subjects Who Achieve and Then Lose Response within 4
Hours? Headache 2004;44:482-483.
Rapoport AM, Tepper SJ, Sheftell FD, Bigal ME. Levetiracetam in the Preventive
Treatment of Transformed Migraine. Headache 2004;44:517.
Bigal ME, Lipton RB, Rapoport AM, Tepper SJ, Sheftell FD. The Classification of
Chronic Daily Headache in Adolescents and Adults. Headache 2004;44:519-520.
Bigal ME, Sheftell F, Tepper SJ, Rapoport AM, Lipton RB. Migraine Days Decline with
Duration of Illness in Adolescents with Transformed Migraine. Headache 2004;44:520.
Sheftell FD, Bigal ME, Rapoport AM, Tepper SJ. Assessment of Adverse Events
Asssociated with Triptans. Neurology 2004;62(Suppl 5):A81.
Rapoport AM, Tepper SJ, Sheftell FD, Bigal ME. Levetiracetam in the Preventive
Treatment of Transformed Migraine. A Prospective Study. Neurology 2004;62(Suppl
5):A147.
Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB. Chronic Daily Headache in
Adolescents and Adults. A Comparative Study. Neurology 2004;62(Suppl 5):A337.
Bigal MB, Lipton RB, Tepper SJ, Sheftell FD, Rapoport AM. Evolution of Transformed
Migraine in Adolescents: Migraine Days Decline with Duration of illness. Neurology
2004;62(Suppl 5):A442.
Dowson AJ, Cady RK, Tepper SJ, Smith TR, Shapero G. Pharmacologic management of
migraine. Ann Intern Med. 2004;140:W26.
Dowson AJ , Tepper SJ, Baos V, D’Amico D, Baudet F, Kilminster S. The Migraine
Assessment of Current Therapy (Migraine-ACT) Questionnaire: a new assessment tool to
identify patients who require a change in their current acute migraine treatment.
Cephalalgia 2004;24:1093.
Dahlof C, Aurora S, Rapoport AM, Tepper SJ, Sheftell FD, Bigal ME. Satisfaction with
Current Migraine Acute Treatment. A Multicentric Study. Headache 2005;45:781-782.
Dahlof C, Aurora S, Rapoport A, Tepper S, Bigal M. Satisfaction with current therapy.
Experience from 3 centers in US and Sweden. Neurology 2005;61(suppl 1): 336.
Bigal ME, Tepper SJ, Rapoport AM, Sheftell FD, Lipton RB. Chronic Migraine Is an
Earlier Stage of Transformed Migraine in Adults. Headache 2005;45:769-770.
65
Bigal M, Feleppa M, Tepper S, Rapoport AM. The prevention outcome and body mass
index. Neurology 2005;61(suppl 1):132-133.
Lipton R, Rapoport A, Tepper S, Bigal M. The classification of chronic daily headaches
in adolescents. Neurology 2005;61(Suppl 1):133
Rapoport AM, Dahlof C, Aurora SK, Tepper SJ, Bigal ME, Sheftell FD. Zolmitriptan
Nasal Spray in the Acute Treatment of Migraine. A Preference Study. Headache
2005;45:805-806.
Bigal ME, Rapoport AM, Tepper SJ, Sheftell FD, Lipton RB. Headache Prevention
Outcome and Body Mass Index. Headache 2005;45:827-828.
Sheftell FD, Tepper SJ, Rapoport AM, Bigal ME. Naratriptan in the Preventive
Treatment of Refractory Transformed Migraine. A Prospective Pilot Study. Headache
2005;45:818.
Meskunas C, Sheftell F, Rapoport A, Tepper S, Bigal M. Medications Associated with
Probable Medication Overuse Headache Reported in a Tertiary Care Headache Center
over a 15-Year Period. Neurology 2006;66 (Suppl 2):A141.
Silberstein SD, Mauskop A, Dodick DW, Frishberg BM, Tepper SJ, McAllister P, Aurora
SK, Loder EW, Freitag FG. Program to Assess headache Treatment Strategies: An
Observational Study of Botulinum toxin type A in the Preventive treatment of headache.
Headache 2006;46:846-847.
Rapoport AM, Dahlof CG, Aurora S, Tepper SJ, Sheftell FD, Bigal ME. Consistency of
Efficacy of Zolmitriptan Nasal Spray vs. Usual Care in the Acute Treatment of Migraine.
Headache 2006;46:864.
Bigal ME, Sheftell FD, Tepper SJ, Rapoport AM, Lipton RB. Field Testing Alternative
Criteria for Chronic Migraine. Headache 2006;46:836-837.
Bigal ME, Meskunas C, Tepper SJ, Rapoport AM, Sheftell FD. Medications Associated
with Probable Medication Overuse Headache Reported in a Tertiary Care Headache
Center Over a 15-year Period. Headache 2006;46:894.
Silberstein SD, Mauskop A, Dodick DW, Frishberg BM, Tepper SJ, McAllister P, Aurora
SK, Freitag FG. Predictors of outcomes with botulinum toxin type a in the preventive
treatment of headache. Cephalalgia 2006;26:1371.
Peterlin BL, Bigal ME, Urakaze MU, Rapoport AM. Migraine and adiponectin: is there a
connection? Cephalalgia 2006;26:1385.
66
Rapoport AM, Mathew N, Silberstein S, Dodick D, Sheftell F, Tepper S, Choyce L, Bigal
M. Zolmitriptan Nasal Spray in the Acute Treatment of Cluster Headache- A DoubleBlind, Placebo-Controlled, Multicentric Study. Neurology 2007;68 (Suppl 1):A261;
also Headache 2007;47:766.
Liebenstein M, Bigal M, Sheftell F, Tepper S, Rapoport A, Lipton R. Validation of the
Chronic Daily Headache Questionnaire (CDH-Q). Neurology 2007;68 (Suppl 1):A369;
also Headache 2007;47:760-761.
Tepper SJ, Kruep EJ, Runken MC, Chakravarty S. Treatment Patterns for Migraine
Headache: A Managed Care Perspective. Headache 2008; 48:S47-S48.
Tepper SJ, Bigal ME, Sheftell FD, Zatochill MK, Szeto M. Development of a Simple
Menstrual Migraine Screening Tool for Obstetric and Gynecology Clinics. American
College of Obstetrics and Gynecology meeting, May 5, 2008, New Orleans, LA.
Tepper SJ, Kruep EJ, Runken MC, Chakravarty S. Treatment Patterns for Migraine
Headache: A Managed Care Perspective. Headache 2008;S46-47.
Tepper SJ, Bigal ME, Sheftell FD, Zatochill MK, Szeto M. Development of a Simple
Menstrual Migraine Screening Tool for Obstetric and Gynecology Clinics. Nurse
Practitioners in Womens Health meeting, Oct 16, 2008, Seattle, WA.
Ansarinia M, Rezai A, Stanton-Hicks M, Machado A, Tepper S, Steiner C, Stump J,
Deogonokar M, Francisoco A, Narouze S. Stimulation of Sphenopalatine Ganglion
(SPG) for Treatment of Acute Cluster Headaches. North American Neuromodulation
Society meeting, Dec 5, 2008, Las Vegas, NV.
Narouze S, Rezai A, Tepper SJ, Mohajer P, Ansarinia M. Sphenopalatine Ganglion
Stimulation for the Acute Treatment of Intractable Migraine. American Academy of Pain
Medicine meeting, Jan 28-31, 2009, Honolulu, HI.
Tepper SJ, Kruep EJ, Runken MC, Chakravarty S. Treatment Patterns for Migraine
Headache: A Managed Care Perspective. Diamond Headache Symposium, Phoenix, AZ,
Feb 10, 2009 (platform presentation).
Cherian N, Stillman MJ, Gargano F, Whalen V, Tepper SJ. Cervicogenic Headache: A
possible manifestation of peripheral vestibular dysfunction? Neurology 2009;72 (11,
Supplement 3):A176.
Kung E, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. New Daily Persistent
Headache in the Pediatric Population. Neurology 2009;72 (11, Supplement 3):A253.
Also presented at the American Academy of Pain Medicine, February 3-6, 2010, San
Antonio, TX.
67
Tepper SJ, Rezai AR, Narouze S, Machado A, Steiner C, Stump J, Ansarinia M. Acute
Treatment of Medically Refractory Cluster Headache by Electrical Stimulation of
the Sphenopalatine Ganglion (SPG). Neurology 2009;72 (11, Supplement 3):A90-91.
Rezai AR, Ansarinia M, Narouze S, Steiner C, Machado A, Francisco A, Deogaonkar M,
Tepper SJ. Stimulation of Sphenopalatine Ganglion (SPG) for Treatment of Severe Acute
Cluster Headaches. World Society for Stereotactic and Functional Neurosurgery,
Toronto, May 24-27, 2009.
Tepper SJ, Kori SH, Mathew NT, Saper JR, Winner PD, Freitag FG, Borland SW, Wang
M, Hu B, Silberstein SD. Efficacy evaluation of LEVADEX™ (previously MAP0004) in
treating resistant migraine including migraine with allodynia, morning migraine,
disabling migraine and migraine treated late in its cycle. 14th International Headache
Congress, Philadelphia, PA, Sept 10-12, 2009.
Silberstein SD, Kori S, Tepper SJ, Borland SW, Wang W, Reppine AE, Amer TA,
Dodick DW. LEVADEX, a novel orally inhaled treatment for acute migraine: efficacy
and tolerability results of a Phase 3 study. 14th International Headache Congress,
Philadelphia, PA, Sept 10-12, 2009 (LBPOR4, PO04). Cephalalgia 2009;29 (Suppl
1):12-13.
Ansarinia M, Rezai A, Tepper SJ, Mohajer P, Steiner CP, Stanton-Hicks M, Narouze S.
Sphenopalatine Ganglion (SPG) stimulation during Acute Migraine and Cluster
Headaches. 14th International Headache Congress, Philadelphia, PA, Sept 10-12, 2009
(PO39). ). Cephalalgia 2009;29 (Suppl 1):27.
White C, Tepper SJ, Stillman MJ. Dihydroergotamine and Its Use in Migraine with
Posterior Fossa Symptoms. 14th International Headache Congress, Philadelphia, PA,
Sept 10-12, 2009 (PO26). ). Cephalalgia 2009;29 (Suppl 1):21.
Cherian N, Stillman MJ, Gargano F, Whalen V, Tepper SJ. Cervicogenic Headache: A
possible manifestation of peripheral vestibular dysfunction? 14th International Headache
Congress, Philadelphia, PA, Sept 10-12, 2009 (PO288). ). Cephalalgia 2009;29 (Suppl
1):123.
Tepper SJ, Liu K, Jones SE, Phillips MD, Stillman MJ, Horvat M, Lowe MJ. Functional
MRI Suggests Iron Deposition in Pain Regulatory Nuclei in Episodic Migraine and
Chronic Daily Headache. (SC02.006) American Academy of Neurology meeting, Toronto,
Ontario, April 2010. Neurology 2010;74(Suppl 2):A591.
Tepper SJ, Kori SH, Borland SW, Wang M, Hu B, Silberstein SD. Evaluation of Efficacy
and Safety of MAP0004 in Reversing Central Sensitization and Treating Migraines in
Established Allodynic Patients. (P04.007) American Academy of Neurology meeting,
Toronto, Ontario, April 2010. Neurology 2010;74(Suppl 2):A321.
68
Stillman MJ, Foudad-Terazi F, Zhou L, Tepper SJ, Cherian N. The Identification and
Characterization of Autonomic Dysfunction in Migraineurs with and without Auras.
(P04.248). American Academy of Neurology meeting, Toronto, Ontario, April 2010.
Neurology 2010;74 (Suppl 2):A379.
Baron EP, Moskowitz S, Tepper SJ. Headache Following Intracranial Endovascular
Procedures. American Headache Society meeting, LA, CA June 2010. Headache 2010;50
(June 2010):S7-8; also Headache 2010;50(S1):7-8.
Stillman M, Fouad F, Cherian N, Tepper S, Zhou L. The Identifaction and
Characterization of Autonomic Dysfunction in Migraineurs with and without Auras:
Phase I. American Headache Society Scientific meeting, LA, CA, June 2010. Headache
2010;50 (June 2010): S10, also Headache 2010;50(S1):10.
Tepper SJ, Lowe MJ, Liu K, Phillips MD, Stillman MJ, Horvat M, Jones SE. Iron
Deposition in Pain Regulatory Nuclei in Episodic Migraine and Chronic Daily Headache
as Measured for Functional MRI. Platform presentation at the American Headache
Society scientific meeting, LA, June 2010; Headache 2010;50 (June 2010): S59; also
Headache 2010;50(S1):60.
Tepper SJ, Kori SH, Goadsby PJ, Winner PK, Wang MH, Silberstein SD. Utility of
Levadex in Situations Where Early Intervention Paradigm is Impractical. Platform
presentation at the American Headache Society scientific meeting, LA, June 2010;
Headache 2010;50 (S1):72. ; J. Headache and Pain 2010;11(Supplement 1):462.
Kori S, Silberstein S, Aurora S, Tepper S, Borland S, Wang M, Reppine A, Armer T,
Dodick D. Levadex, a novel orally inhaled treatment for acute migraine: efficacy and
tolerability results of a Phase 3 study. 2d European Headache and Migraine Trust
International Congress, Nice France, Oct, 2010. J. Headache and Pain
2010;11(Supplement 1):462. DOI 10.1007/s10194-010-0259-3.
Kori S, Tepper S, Mathew N, Saper J, Winner P, Freitag F, Borland S, Wang M, Hu B,
Silberstein S. Efficacy evaluation of Levadex in treating resistant migraine including
migraine with allodynia, disabling migraine and migraine treated late. 2d European
Headache and Migraine Trust International Congress, Nice France, Oct, 2010.
J. Headache and Pain 2010;11 (Supplement 1):464. DOI 10.1007/s10194-010-0259-3.
Kori S, Tepper S, Boland S, Wang M, Hu B, Silberstein S. Evaluation of efficacy and
safety of Levadex (MAP0004) in reversing central sensitization and treating migraine in
established allodynic patients. 2d European Headache and Migraine Trust International
Congress, Nice France, Oct, 2010. J. Headache and Pain 2010;11(Supplement 1):466.
DOI 10.1007/s10194-010-0259-3.
69
Tepper S, Kori S, Goadsby P, Ferrari M, Lipton R, Borland S, Wang M, Kellerman D,
Dodick D. Migraine Recurrence Rates: Case for Standardization of the Definition. 2d
European Headache and Migraine Trust International Congress, Nice France, Oct,
2010; J. Headache and Pain 2010;11(Supplement 1):471. DOI 10.1007/s10194-0100259-3.
Kori SH, Tepper SJ, Goadsby PJ, Winner PK, Wang MH, Silberstein SD. Utility of
Levadex in situations where early intervention paradigm is impractical. J. Headache and
Pain 2010;11(Supplement 1):322. DOI 10.1007/s10194-010-0259-3. Platform
presentation at the 2d European Headache and Migraine Trust International Congress,
Nice France, Oct 31, 2010; Neurology 2011;76 (Suppl 4):A266-A267.
Kori S, Tepper S, Goadsb PJ, Wommer P, Wang M, Silbestein SD. Utility of OralyInhaled Dihydroergotamine When Early Intervention is Impractical. 136th Meeting of the
American Neurological Association, Sept 27, 2011; Poster T1603.
Tepper SJ, Kori SH, Goadsby P, Ferrari M, Lipton R, Borland S, Wang M, Kellerman D,
Dodick D. Migraine Recurrence Rates: Case for Standardization of the Definition.
Neurology 2011;76 (Suppl 4):A444-A445. Also presented at the 136th Meeting of the
American Neurological Association, Sept 27, 2011; Poster T1617.
Almas M, Tepper S, Landy S, Ramos É. Eletriptan Provides Consistent Migraine
Relief: Results of a Within−Patient Multiple−Dose Study, accepted as scientific abstract
number 3163 for the American Academy of Neurology meeting, New Orleans, LA, April
24, 2012. Also, American Headache Society 54th Annual Scientific meeting, Los Angeles,
CA. Headache 2012;52(5):886; Poster 32.
Landy S, Tepper S, Wein T, Schweizer E, Ramos E. An Open-Label Trial of Alsuma
Auto-Injector for Migraine. American Headache Society 54th Annual Scientific meeting,
Los Angeles, CA. Headache 2012;52 (5):877; Poster 12.
Peterlin BL, Tietjen GE , Gower BA , White LW, Hammond E, Dash PD, Ward TN,
Tepper SJ, Haythornthwaite JA. Adiponectin (ADP) & ADP Oligomers are Differentially
Modulated by Treatment Response in Episodic Migraineurs. American Neurological
Association meeting, Boston, MA, Sept 2012.
Almas M, Tepper S, Landy S, Ramos É. Eletriptan Provides Consistent Migraine
Relief: Results of a Within−Patient Multiple−Dose Study, American Academy of
Neurology meeting, New Orleans, LA, April 24, 2013.
Zheng Y, Tepper S, Covington E, Mathews M, Scheman J. Pain Rehabilitation: Can It
Help Patients with Intractable Headache? Cephalalgia 2013;33(Supplement 8): 80
[International Headache Congress, Poster 96, Boston, MA, June 27-30, 2013].
Tsai K, Tepper SJ, Bloudek LM, Messali A, Kori SH. Adherence and Persistence to
Triptans for Acute Migraine: A Systematic Literature Review. Academy of Managed
Care Pharmacy, San Antonio, TX, Oct 15-18, 2013.
70
Thorland K, Sun-Edelstein C, Kanters S, Druyts E, Eapen S, Ebrahim S, Bhambri R,
Ramos E, Mills EJ, Lantéri-Minet M, Tepper S. Risk of medication overuse headache
across classes of treatment for migraine. American Headache Society 56th Annual
Scientific Meeting, Los Angeles, California, June 26-29, 2014 (late break).
Tepper SJ, Newman L, Holdbrook F, Earl NL, Davar G. Comparable Efficacy and Safety
For Exploratory Endpoints Regardless of Pain Severity and Treatment Time After
Migraine Onset: Results From a Phase 3 Trial of Orally Inhaled Dihydroergotamine
(MAP0004) for the Acute Treatment of Migraine. Headache 2014;54(S1):13-14.
American Headache Society 56th Annual Scientific Meeting, Los Angeles, California,
June 26-29, 2014.
Vij B, Vutien P, Horvat M, Tepper DE, Tepper SJ. OnabotulinumtoxinA in the Treatment
of New Daily Persistent Headache (NDPH). Headache 2014;54(S1):57. American
Headache Society 56th Annual Scientific Meeting, Los Angeles, California, June 26-29,
2014.
Tepper S, Cady R, Silberstein S, Messina J, Mahmoud R, Djupesland PG, Shin P, Siffert
J. A randomized, double-blind, double-dummy, active-comparator crossover study of
Breath Powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of
acute migraine (the COMPASS study). Poster at: 56th Annual Meeting of the American
Headache Society; June 26-29, 2014; Los Angeles, CA. Abstract LBP37.
Tepper SJ, Mechtler, LL, Kudrow DB, Silberstein SD, Calhoun AH, Lipton RB, Spitzer
L, Mullin C, Liebler EJ; on behalf of the ACT Study Group. Clinical Effects of
gammaCore for Rescue Treatment of Acute Cluster Headache: Report from the Doubleblind Phase of Acute Cluster Headache Treatment (ACT) Study. 4th European Headache
Federation and Migraine Trust International Congress, Copenhagen, Denmark, Sept 1821, 2014.
Silberstein SD, Mechtler LL, Kudrow DB, Tepper SJ, Calhoun AH, Lipton RB, Spitzer
L, Mullin C, Liebler EJ; on behalf of the ACT Study Group. Efficacy and Safety of Noninvasive Vagus Nerve Stimulation With GammaCore for the Abortive Treatment of
Acute Cluster Headache: Report From the Double-blind Stage of the Acute Cluster
Headache Treatment (ACT) Study. 4th European Headache Federation and Migraine
Trust International Congress, Copenhagen, Denmark, Sept 18-21, 2014.
Tepper S, Cady R, Silberstein S, Messina J, Mahmoud R, Djupesland P, Shin P, Siffert J.
Primary Efficacy Outcomes from COMPASS: A Comparison of Breath Powered
Device Containing 22 mg Sumatriptan Powder (AVP-825) Versus 100 mg Oral
Sumatriptan in Acute Treatment of Migraine. Neurology. 2015;84(14 Suppl).
American Academy of Neurology, Washington, DC, April 22, 2015. Poster
S23.001. Platform presentation.
71
Tepper S, Cady R, Messina J, Mahmoud R, Djupesland P, Shin P, Siffert J.
Secondary efficacy outcomes from COMPASS: a comparison of Breath Powered
device containing 22 mg sumatriptan powder (AVP-825) versus oral 100 mg
sumatriptan in episodic migraine [AAN 2015 abstract P3.059]. Neurology.
2015;84(14 Suppl).
Silberstein S, Tepper SJ, Cady RK, Messina J, Mahmoud RA, Djupesland PG, Shin P,
Siffert J, Siegert S, Wallick C. Secondary Efficacy Outcomes from COMPASS:
Comparison of a Breath Powered Delivery System Containing 22 mg Sumatriptan
Powder (AVP-825) Versus Oral 100 mg Sumatriptan in Episodic Migraine. 27th
American Academy of Managed Care Pharmacy, San Diego, CA, Apr 7-10, 2015, also
American Academy of Neurology, Washington, DC, April 21, 2015.
Halker R, Tepper S, Siegert S, Wallick C. Total migraine freedom for Breath Powered
intranasal delivery of 22mg sumatriptan powder (AVP-825) versus 100mg oral
sumatriptan from the COMPASS study in acute migraine. Oral Presentation at: 17th
Biennial Congress of the International Headache Society; May 14-17, 2015; Valencia,
Spain.
Maasumi K, Thompson NR, Kriegler JS, Tepper SJ. Effect of OnabotulinumtoxinA
Injection on Depression in Chronic Migraine. 17th International Headache Congress,
Valencia, Spain, May 14-15, 2015.
Tariq N, Tepper SJ, Kriegler J. Long term outcomes in hypnic headache syndrome: 32
patient series from a tertiary referral center. 17th International Headache Congress,
Valencia, Spain, May 15-16, 2015. Platform presentation, American Headache Society
57th Scientific Meeting, Washington, DC, June 18-21, 2015.
Tariq N, Estemalik E, Afzal MR, Mays M, Tepper SJ, Kriegler J. Geographic
Distribution and Demographic Characteristics of United Council of Neurologic
Subspecialties (UCNS) Certified Headache Specialists Across the United States.
American Headache Society 57th Scientific Meeting, Washington, DC, June 18-21, 2015.
Halker, R, Tepper, SJ.Siegert S, Wallick C. Total Migraine Freedom for Breath Powered
Intranasal Delivery of 22 mg Sumatriptan Powder (AVP-825) Versus 100 mg Oral
Sumatriptan from the COMPASS Study of Acute Treatment of Migraine. Headache.
2015;55(Suppl 3):136. American Headache Society 57th Scientific Meeting, Washington,
DC, June 18-21, 2015.
Halker R, Tepper S, Siegert S, Wallick C. Total migraine freedom for Breath Powered
intranasal delivery of 22mg sumatriptan powder (AVP-825) versus 100mg oral
sumatriptan from the COMPASS study of acute treatment of migraine [ISPOR-Int 2015
abstract]. Value Health. 2015;18(3):A278.
72
Tepper SJ, Cady R, Messina J, Mahmoud R, Djupesland P, Shin P, Siffert J, Siegert S,
Wallick C. Secondary efficacy outcomes from COMPASS: a comparison of Breath
Powered device containing 22 mg sumatriptan powder (AVP-825) versus oral 100 mg
sumatriptan in episodic migraine. Poster at: 27th Annual Meeting and Expo of the
Academy of Managed Care Pharmacy; April 7-10, 2015; San Diego, CA.
Tariq N, Estemalik E, Adil M, Tepper SJ. Kriegler J. Safety and Efficacy of
OnabotulinumtoxinA for chronic migraines in the elderly. A comparison with
PREEMPT-II clinical trial. American Headache Society 57th Scientific Meeting,
Washington, DC, June 18-21, 2015.
Clinical Studies list provided on request
Dr. Tepper has participated and completed more than 300 clinical trials since 1990. He
participated in 10-30 trials on an ongoing basis at The New England Research Institute
from 1999-2007, and a list can be provided. He was Co-Director of Research at the
Center for Neurological Restoration, Neurological Institute, Cleveland Clinic until 2015,
and had multiple clinical trials underway, with studies in new formulations, monoclonal
antibodies, and devices.
Personal Information
Home Address:
PO Box 355
105 Melody Lane
South Chatham, MA 02659
Home Phone:
508-432-7121
Marital Status:
Married; two sons
73